Page last updated: 2024-08-24

triazoles and rizatriptan

triazoles has been researched along with rizatriptan in 308 studies

Research

Studies (308)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's37 (12.01)18.2507
2000's206 (66.88)29.6817
2010's59 (19.16)24.3611
2020's6 (1.95)2.80

Authors

AuthorsStudies
Baker, R; Beer, MS; Davey, WB; Guiblin, AR; Jelley, RA; Reeve, AJ; Routledge, H; Sternfeld, F; Street, LJ; Watt, AP1
Brown, MJ; Ferro, A; Hill, RG; Longmore, J1
Block, G; Cheng, H; Claghorn, J; Cutler, NR; Olah, TV; Panebianco, D; Reines, SA; Sramek, JJ1
Barrish, A; Dobrinska, MR; Gatto, GJ; Gilbert, JD; Michel, KB; Olah, TV1
Ellis, JD; Gilbert, JD; Halpin, RA; McLoughlin, DA; Olah, TV1
Boulanger, CM; Desta, B; Hill, RG; Longmore, J; Schofield, WN; Taylor, AA1
Ferrari, MD; Jiang, K; Lines, CR; Reines, SA; Terwindt, GM; Visser, WH1
Cerchio, KA; Cheng, H; Christie, K; James, I; McLoughlin, D; Olah, TV; Polvino, WJ; Rogers, JD; Sciberras, D; Yogendran, L1
Cheng, H; Edwards, M; Gertz, BJ; Mant, T; Olah, T; Polvino, WJ; Sciberras, DG; Stepanavage, M; Wittreich, J1
Egan, R; Walden, S; Wang, T1
Cumberbatch, MJ; Hargreaves, RJ; Hill, RG1
Hargreaves, RJ; Hill, RG; Shepheard, SL; Williamson, DJ2
Block, G; Ferrari, MD; Gijsman, H; Kramer, MS; Matzura-Wolfe, D; Polis, A; Sargent, J; Teall, J; Tuchman, M1
Block, GA; Hartmaier, SL; Kramer, MS; Polis, AB; Santanello, NC; Silberstein, SD1
Colpaert, FC; John, GW; Pagniez, F; Valentin, JP; Vieu, S1
Block, G; Cutler, N; Gross, M; Jiang, K; Reines, S; Smith, B; Teall, J; Tuchman, M; Willoughby, E1
Steiner, TJ1
Bax, WA; Ferrari, MD; MaassenVanDenBrink, A; Reekers, M; Saxena, PR1
Amaraneni, PG; Feighner, J; Getson, A; Kramer, MS; Matzura-Wolfe, D; McHugh, W; Polis, A; Reines, SA; Silberstein, S; Solbach, MP1
Davenport, AP; Hill, RG; Longmore, J; Maguire, J; Pickard, JD; Razzaque, Z; Schofield, WN; Shaw, D1
Blum, RA; Brucker, MJ; Ermlich, SJ; Goldberg, MR; Lee, Y; McLoughlin, DA; Olah, TV; Rogers, JD; Sterrett, AT; Zhao, J1
Hopkins, B; McHarg, A; Melrose, H; Napier, C; Stewart, M; Wallis, R1
Conroy, JA; De Smet, M; Keymeulen, B; Lee, Y; McLoughlin, DA; Mendel, CM; Olah, TV; Rogers, JD; Somers, G; Stepanavage, ME1
Block, GA; Davies, GM; Gerth, W; Lerner, D; Santanello, N1
Ahrens, SP; Block, GA; Farmer, MV; Jiang, K; Visser, WH; Williams, DL; Willoughby, E1
Birk, KL; Cohen, AF; De Puy, ME; De Smet, M; Fisher, AL; Goldberg, MR; Musson, DG; Sterrett, A; Van Gerven, JM; Van Haarst, AD1
Deleu, D; Hanssens, Y2
Hussar, DA1
Allen, C; Bomhof, M; Legg, N; Patel, K; Paz, J; Vandormael, K1
Dooley, M; Faulds, D1
Goadsby, PJ2
Chavez-Eng, C; Cheng, H; Ellis, JD; Geer, LA; Guiblin, AR; Halpin, RA; Liu, L; Matuszewski, BK; Rogers, JD; Varga, SL; Vyas, KP1
Brucker, MJ; Ermlich, SJ; Goldberg, MR; Lee, Y; McLoughlin, DA; Olah, TV; Panebianco, D; Shadle, CR; Slaughter, DE; Vyas, KP1
Bartlett, MG; Stewart, JT; Vishwanathan, K1
Logemann, CD; Rankin, LM1
Goldberg, MR; Liu, G; Shadle, CR1
Leira, R; Pascual, J1
Adelman, JU; Mannix, LK; Von Seggern, RL1
Chernyshev, O; Gentry, P; Kailasam, J; Mathew, NT1
Dahlof, CG; Lines, CR; Rapoport, AM; Sheftell, FD1
Johnson-Pratt, L; Le Jeunne, C; Lines, CR; Massiou, H; McCarroll, KA; Silberstein, SD1
Bartleson, JD1
Tfelt-Hansen, P2
Allen, C; Diener, HC; Pascual, J; Patel, K; Vega, P; Vrijens, F1
de Hoon, JN; Struijker-Boudier, HA; Troost, J; Van Bortel, LM; Willigers, JM1
Scholz, M1
Davies, GM; Lipton, R; Santanello, N1
Klapper, JA; O'Connor, S1
Ferrari, MD1
Hargreaves, RJ2
Sakai, F2
Pascual, J2
Goadsby, PJ; Lipton, RB1
Goadsby, PJ; Hargreaves, RJ1
Saper, JR2
Ryan, RE; Tfelt-Hansen, P1
Silberstein, SD1
Santanello, N; Solomon, GD1
Dahlöf, CG; Ferrari, MD; Kramer, MS; Lines, CR; Lipton, RB; McCarroll, KA1
Potrebic, S; Raskin, NH1
Carides, GW; Dasbach, EJ; Gerth, WC; Pigeon, JG; Santanello, NC1
Gawel, M; Wiebe, S1
Göbel, H; Heinze, A; Heinze-Kuhn, K; Lindner, V1
Allen, C; Dayno, J; Lines, C; McCarroll, K1
Allen, C; Bussone, G; Hernandez, JF; Pascual, J; Patel, K; Vrijens, F1
Hashimoto, S; Iwata, M1
Ferrari, MD; Lines, CR; Loder, E; McCarroll, KA1
Lines, CR; Malbecq, W; Vandormael, K1
Allen, C; Cady, R; Lines, C; McCarroll, K1
Berger, M; Frishberg, B; Hu, XH; Markson, L; Solomon, S1
Marcus, DA1
De Smet, M; Goldberg, MR; Halpin, R; James, I; Kari, PH; Lee, Y; Lowry, R; Olah, TV; Sciberras, D; Tomasko, L; Vyas, KP; Zhao, J1
Ahrens, S; Cady, R; Crawford, G; Getson, A; Hairwassers, D; Lines, C; Visser, WH1
Rapoport, AM; Tepper, SJ1
Birk, KL; De Puy, ME; Fisher, A; Goldberg, MR; Lowry, RC; Musson, DG; Shadle, CR1
Bohidar, N; Boyle, D; Brandes, JL; Guerra, F; Johnson-Pratt, L; Kolodny, A; Loder, E; Santanello, N; Silberstein, S; Skobieranda, F; Wang, L1
Goadsby, PJ; Jiang, K; Lines, CR; Lipton, RB; Massiou, H; McCarroll, KA; Pascual, J; Vandormael, K1
Adelman, JU; Diener, HC; Ferrari, MD; Lines, CR; Lipton, RB; McCarroll, KA; Vandormael, K1
Birk, KL; Gagliano, KD; Goldberg, MR; Musson, DG; Panebianco, DL; Rogers, JD1
McQuay, HJ; Moore, RA; Oldman, AD; Smith, LA1
Gerth, WC; Mannix, LK; McCarroll, KA; Santanello, NC; Vandormael, K; Zhang, Q1
Lipton, RB; Newman, LC1
Diener, HC; Fritsche, G; Katsarava, Z; Limmroth, V; Muessig, M1
Ferrari, MD; Goadsby, PJ; Lipton, RB; Roon, KI1
Freitag, FG1
Vigl, M; Wessely, P; Zebenholzer, K1
Allen, C; Lines, C; McCarroll, K1
Berger, ML; Cowan, R; Hu, XH; Markson, LE; Raskin, NH1
Ahrens, S; Evans, JK; Jiang, K; Lewis, D; Visser, WH; Winner, P1
Fité, B; López-Gil, A; Pascual, J1
Plosker, GL; Wellington, K1
Baggen, S; Cohen, AF; Fuseau, E; Pereira, A; Pieters, MS; Schoemaker, RC; Schram, MT; van der Post, J; van Gerven, JM1
Barbosa, JS; Krymchantowski, AV1
Lines, C; Seidelin, K; Stepanavage, M; Tfelt-Hansen, P1
Rapoport, AM; Sheftell, FD; Tepper, SJ1
Csiba, L; Ficzere, A1
Login, IS1
Rieder, MJ1
Jarvis, B; Wellington, K1
Bussone, G; D'Amico, D; Gerth, W; Lines, CR; McCarroll, KA1
Lines, C; McCarroll, K; Tfelt-Hansen, P1
Allen, C; Davies, G; Kramer, M; Lipton, R; Santanello, NC1
Lines, CR; Massiou, H; McCarroll, KA; Silberstein, SD1
Maizels, M1
Lines, CR; McCarroll, KA; Visser, WH1
Allen, C; Christie, S; Göbel, H; Mateos, V; Shivaprakash, M; Vrijens, F1
López Rodríguez, I; López-Gil, A; Mateos, V; Roig, C1
Cutrer, FM; Dayno, J; Goldstein, J; Hu, XH; Jamieson, D1
Adelman, JU; Lewit, EJ1
Allen, C; Evans, DC; Evers, R; Hargreaves, R; Lake, BG; O'Connor, D1
Cano Orgaz, A; Ceballos Hernansanz, MA; López-Gil, A; Sanchez Roy, R1
John, GW; Létienne, R; Verscheure, Y1
Gawel, M; Gladstone, JP1
Bokish, N; Dashkovsky, E; Derazon, H; Hay, E; Hussain, A; Kafka, M; Kopelovitch, G; Nassimyan, S; Rodrig, J; Shtibelman, I1
Hara, K; Ishizaki, T; Iwasa, T; Nakagawa, K; Okochi, H; Sano, H; Sugiura, A; Uchiyama, N; Yasumori, T1
Grubisa, HS; Major, PW; Thie, NM1
Baos, V; Bertral, C; Caloto, MT; Gerth, WC; Nocea, G; Serrano, A; Torrecilla, M1
Diener, HC; Lines, CR; McCarroll, KA; Silberstein, SD1
Reeder, CE; Williams, P1
Burstein, R; Collins, B; Jakubowski, M1
Gerth, WC; Hu, XH; Sarma, S; Silberstein, SD1
Hale, R; Hodges, C; Lloyd, P; Lu, A; Mufson, D; Myers, D; Rabinowitz, JD; Shen, W; Wensley, M; Zaffaroni, A1
Cabarrocas, X1
Ashcroft, DM; Millson, D1
Iizuka, T; Sakai, F1
Aijima, H; Ikemoto, F; Natsumeda, Y; Toru, T1
Chen, J; Gao, X; Jiang, W; Jiang, X; Mei, N; Zhang, Q1
Jähnichen, S; Pertz, HH; Radtke, OA1
Battisti, WP; Johnson-Pratt, L; Kolodny, A; Polis, A; Skobieranda, F1
Bigal, ME; Krymchantowski, AV2
Dodick, DW; Ferrari, MD; Goadsby, PJ; McCrory, DC; Williams, P1
Tomson, T; Vetr, A; Vitols, S1
Cady, R; Klipfel, M; Lewis, D; McCarroll, K; Nett, R; Peng, Y; Strohmaier, K; Visser, WH; Winner, P1
Adelman, J; Cady, R; Diamond, M; Hu, XH; Martin, V; Sajjan, S1
López-Gil, A1
Burke, TA; Laínez, MJ; Vicente-Herrero, T1
Kowa, H; Nakashima, K; Takeshima, T1
Igarashi, H1
Morillo, LE2
Brucker, MJ; Carides, AD; Cutler, NR; Goldberg, MR; Jhee, SS; Kramer, MS; Majumdar, AK; Matzura-Wolfe, D; McLaughlin, D; Reines, SA1
Muñoz, P; Pascual, J1
Göbel, H2
Chen, J; Gao, XL; Jiang, WM; Jiang, XG; Mei, N1
Bellini, G; Bonanni, E; Gori, S; Iudice, A; Manca, L; Morelli, N; Murri, L; Orlandi, G1
Edvinsson, L; Ingemansson, R; Jarvius, M; Malmsjö, M; Wackenfors, A1
Davenport, A; Edvinsson, L; Longmore, J; Malmsjö, M; Uddman, E; Wackenfors, A1
Healey, PJ; Mullins, CD; Perfetto, EM; Subedi, PR; Weis, KA1
Kobayashi, M; Mori, T; Okazawa, H; Pagani, M; Tanaka, F; Tsuchida, T; Yonekura, Y1
Gao, HZ; Guo, JF; Liu, ZY; Qiao, SY; Sun, XH; Zhang, AJ; Zhao, L; Zhao, YM1
Capuano, A; Di Trapani, G; Evangelista, M; Ferraro, D; Mei, D; Pierguidi, L; Vollono, C1
Hay, JW; Zhang, L1
Lewis, DW; Sowell, M; Winner, P; Yonker, M1
Chen, J; Jiang, WM; Jin, L; Liang, XG; Mei, N; Xie, YL1
Desjardins, B; Ferko, N; Gawel, M; Grima, D; Thompson, M1
Fiore, M; Goldberg, MR; Santanello, N; Shields, KE1
García-Moncó, C; López-Gil, A; Pascual, J; Roig, C; Yusta Izquierdo, A1
Foster, RH; McCormack, PL1
Furman, JM; Marcus, DA2
Kitagawa, Y; Okuma, H; Takagi, S1
Alcorn, H; Hustad, CM; Ramsey, KE; Rodgers, A; Skobieranda, F; Swan, SK; Woll, S1
Allais, G; Allen, C; Evers, S; Kinge, E; Láinez, MJ; Lis, K; Massaad, R; Rao, NA1
Alberti, A; Calabresi, P; Floridi, A; Maggioni, F; Pini, LA; Rossi, C; Sarchielli, P; Zanchin, G1
Diener, HC; Katsarava, Z; Krobot, KJ; Liedert, B; Limmroth, V; Yoon, MS1
Auvin, S; Cuvellier, JC; Joriot, S; Vallée, L1
Arpitha, Ch; Chandrasekhar, KB; Lalitha Devi, M; Madhavan, P; Mallikarjuna Rao, B; Rajendra Kumar, P; Sangaraju, S; Satya Balaji, T; Srinivasu, MK1
Fulton, JA; Hoffman, RS; Kahn, J; Nelson, LS1
Billups, SJ; Carroll, N; Delate, T; Gershovich, OE; Hoffman, CK1
Cady, R; Hustad, CM; Martin, V; Mauskop, A; Ramsey, KE; Rodgers, A; Skobieranda, F1
Iversen, HK; Tfelt-Hansen, P1
Bigal, ME; Filho, PF; Krymchantowski, AV1
Barlas, S; Bell, CF; Foley, KA; Hu, XH; Solomon, G1
Cheng, X; Hu, T; Que, L; Wu, W1
Chen, Y; Fan, G; Hong, Z; Lin, M; Miao, H; Wu, H; Wu, Y1
Ahonen, K; Eerola, M; Hämäläinen, ML; Hoppu, K1
Almas, M; Elkind, A; Mulhern, SA; Olson, N; Sikes, C; Sunshine, A1
Olesen, J; Tfelt-Hansen, P1
Adani, GL; Baccarani, U; Bresadola, F; Curro, G; Lorenzin, D1
Acuto, G; Caiola, F; Gori, S; Iudice, A; Morelli, N; Murri, L1
Guo, Y; Liao, YH; Liu, CY; Quan, LH; Wang, C1
Hobara, N; Hokama, N; Kameya, H; Ohshiro, S; Sakanashi, M1
Díez, FI; Straube, A; Zanchin, G1
Hustad, CM; Ramsey, KE; Rodgers, A; Skobieranda, F1
Hustad, CM; Loder, E; Mannix, LK; Mueller, L; Nett, R; Ramsey, KE; Rodgers, A; Skobieranda, F1
Chen, Y; Hu, XH; Ma, L; Ng-Mak, DS; Solomon, G1
Asuni, C; Cherchi, A; Congiu, D; Del Zompo, M; Piccardi, MP; Stochino, ME1
Kalita, J; Misra, UK; Yadav, RK3
Cavalheiro, EA; Naffah-Mazzacoratti, Mda G; Peres, MF; Senne Soares, CA; Vieira, DS; Zukerman, E1
Cady, R; Hustad, C; Martin, V; Mauskop, A; Ramsey, K; Rodgers, A; Skobieranda, F1
Gano, D; Gerretsen, P; Silver, S1
Coluzzi, F; De Nardin, M; Facco, E; Liguori, A; Mattia, C; Petti, F; Zanette, G1
Ge, P; Hang, T; Ma, P; Song, M; Wang, L; Zhao, H1
Edward, C; Himmelmann, A; Wallerstedt, SM1
Cady, R; Hustad, CM; Martin, V; Mauskop, A; Ramsey, KE; Rodgers, A; Seidman, LS; Skobieranda, F1
Freitag, F; Hamid, MA; Hustad, CM; Ramsey, KE; Rodgers, A; Skobieranda, F; Taylor, FR1
Huber, VJ; Nakada, T; Tsujita, M1
Mannix, LK1
Ashina, M; Jensen, RH1
Hustad, CM; Mannix, LK; Mueller, L; Nett, R; Ramsey, KE; Rodgers, A; Skobieranda, F1
Davenport, WJ; Dodick, D; Pringsheim, T1
Kotchoubey, B; Larbig, W; Strehl, U; Zank, R1
Mansbach, H; O'Quinn, S; Salonen, R1
Diamond, M; Diamond, S; Freitag, F; Janssen, I; Rodgers, A; Skobieranda, F1
Garg, T; Jain, S; Sharma, A; Singh, HP; Tiwary, AK1
Bigal, M; Ho, TW; Rapoport, A; Sheftell, F; Tepper, D; Tepper, S1
Bharathi, Ch; Kumar, MS; Kumar, PN; Parikh, K; Prabahar, J; Raj, TJ; Sharma, HK1
Evans, RW; Schürks, M1
Hargreaves, RJ; Ho, TW; Lines, CR; Rapoport, AM; Sheftell, FD1
Bigal, ME; Cady, R; Hu, H; Kurth, T; Santanello, N1
Fan, X; Ho, TW; Lines, CR; Rodgers, A; Shapiro, RE; Winner, P1
Bigal, ME; Ho, TW; Rodgers, A1
Bigal, M; Hu, XH; Ng-Mak, DS1
Cady, RK; Connor, KM; Géraud, G; Ho, AP; Ho, TP; Hustad, CM; Martin, VT; Ramsey, KE; Rodgers, A; Zhang, Y1
Evans, RW1
Chawluk, JB1
Jamieson, DG1
Bigal, ME; Cady, RK; Durham, PL; Ho, TW; Vause, CV1
Alkhatib, AA; Gangotena, F; Peterson, KA1
Belvís, R; Kulisevsky, J; Ormazabal, I; Pagonabarraga, J; Ramos, R; Segura, C; Villa, C1
Araki, N; Ito, Y; Kato, Y; Matsuda, H; Suzuki, C1
Ferrari, MD; Lisotto, C; Omboni, S; Pinessi, L; Savi, L; Zanchin, G; Zava, D2
Balaban, CD; Furman, JM; Marcus, DA1
Dong, Z; Jiang, L; Wang, X; Yu, S2
Cady, RK; Ho, TW; Hustad, CM; Martin, VT; Ramsey, KE; Rodgers, AJ; Winner, P1
Ashina, M; Aurora, SK; Connor, KM; Giezek, H; Ho, TW; Jones, C; Lines, C; Loeys, T; Massaad, R; Williams-Diaz, A1
Connor, KM; Fan, X; Friedman, D; Ge, Y; Hewitt, D; Ho, T; Hustad, CM; Lasorda, J; Newman, L; Seeburger, JL; Taylor, FR; Zhang, Y1
Fukuda, M; Kishi, Y; Nakaoku, T; Nakatani, K; Saiki, M; Satow, T1
Airaksinen, M; Hoppu, K; Kaukonen, AM; Klaukka, T; Lindkvist, J1
Chow, MS; Wang, S; Zuo, Z1
Ehrenpreis, ED; Sherid, M1
Cady, RK; Connor, KM; Ge, Y; Ho, TW; Hustad, CM; MacGregor, A; Schaefer, E; Seeburger, JL; Strickler, N; Valade, D; Winner, P; Zhang, Y1
Fraser, IP; Han, L; Han, TH; Hreniuk, D; Li, CC; Linder, S; Stoch, SA; Wagner, JA; Winner, P1
Derry, CJ; Derry, S; Moore, RA1
Aurilia, C; Barbanti, P; Bonassi, S; Dall'Armi, V; Egeo, G; Fofi, L; Vanacore, N1
Acharya, V; Farside, A; MacNeill, R; Moussallie, M; Stromeyer, R; Urbanowicz, B1
Assaid, C; Bachman, R; Connor, K; Hämäläinen, M; Hewitt, DJ; Ho, TW; Lewis, D; Lines, C; Mahoney, E; Michelson, D; Mozley, LH; Pearlman, E; Strickler, N; Zhang, Y1
Assaid, C; Bachman, R; Ceesay, P; Connor, KM; Dupre, N; Hämäläinen, M; Harper Mozley, L; Hewitt, DJ; Ho, TW; Lewis, D; Lines, C; Mahoney, E; Michelson, D; Pearlman, E; Strickler, N1
Casas, M; Dalmau, B; Fernandez-Atutxa, A; Gil, M; Miquel, M; Sanchez-Delgado, J; Vergara, M1
Durham, PL; Masterson, CG1
Kaiser, EA; Kuburas, A; Recober, A; Russo, AF1
Avachat, AM; Gujar, KN; Wagh, KV1
Cavallin, F; Facco, E; Fauci, AJ; Liguori, A; Petti, F; Zanette, G1
Atlin, C; Baran, I; Chanda, ML; Ferrari, MD; Guindi, D; Hathaway, G; Israelian, N; Levenstadt, J; Low, D; Macrae, L; Mariette Lenselink, A; Mogil, JS; O'Shea, L; Silver, A; Spijker, S; Tuttle, AH; van den Maagdenberg, AM; Zendegui, E1
Allais, G; Benedetto, C; Bussone, G; Omboni, S; Pezzola, D; Tullo, V; Zava, D1
Allais, G; Barbanti, P; Benedetto, C; Bussone, G; Cortelli, P; Curone, M; Omboni, S; Peccarisi, C; Pezzola, D; Tullo, V; Zava, D1
Evers, S1
Alvarez-Escudero, R; Pascual, J; Ramón-Carbajo, C1
Guidotti, M; Lisotto, C; Savi, L; Zava, D1
Cui, XP; Lin, H; Lin, M; Mu, JS; Ye, JX1
Burstein, R; Hoaglin, DC; Jakubowski, M; Kam-Hansen, S; Kaptchuk, TJ; Kelley, JM; Kirsch, I1
Bingel, U1
Egan, CG; Mogavero, S; Savi, L1
Kitagawa, Y; Suzuki, Y; Takayanagi, R; Tokuoka, K; Watanabe, M; Yamada, Y1
Han, X; Hao, T; Huang, Q; Yao, G; Yu, T1
Evers, S; Lisotto, C; Omboni, S; Pinessi, L; Savi, L; Zanchin, G1
Kushwah, A; Tomar, A1
Amolkumar, K; Ashok, T; Kiran, J1
Bhagawati, ST; Bhat, K; Chonkar, AD; Dengale, SJ; Reddy, SM1
Afkhami, A; Heidari, M; Madrakian, T; Maleki, S1
Girotra, P; Singh, SK1
Han, X; Li, R; Liu, Y; Ran, Y; Su, M; Tan, Q; Yu, S; Zhang, X1
Ahmadian, E; Eftekhari, A; Eghbal, MA; Fard, JK; Hamzeiy, H; Sattari, M1
Allais, G; Benedetto, C1
Dede, HÖ; Duman, T; Şeydaoğlu, G1
Han, W; Li, M; Wang, J; Xu, H1
Anderson, MO; Jin, BJ; Tradtrantip, L; Verkman, AS; Yao, X1
Hasegawa, A; Hayashi, K; Isozumi, N; Kanai, Y; Kato, Y; Masuo, Y; Nagamori, S; Nakamichi, N1
Hansen, E; Meissner, K; Zech, N1
Crossland, DM; Dieringer, TD; Mahl, TC1
Gurgen, GS; Guvenc, G; Sayin, M; Sayin, SS; Yuceer, N1
Gelfand, AA1
Boddohi, S; Salehi, S1
Moghadamnia, AA; Najafpour, G; Nouri, M; Rahimnejad, M1
Bera, H; Chen, Y; Cun, D; Guo, X; Rantanen, J; Song, Q; Tian, X; Wan, F; Yang, M1
Amundsen, S; Fuskevåg, OM; Nordeng, H; Nordmo, E; Sager, G; Spigset, O1
Fan, GQ; Hou, T; Kou, RZ; Lin, Q; Tao, LM; Wang, L; Yang, F; Yu, XL1
Awasthi, R; Mathure, D; Pawar, A; Ranpise, H1
Khokhlov, AL; Leykin, ZN1

Reviews

67 review(s) available for triazoles and rizatriptan

ArticleYear
Profiles of 5-HT 1B/1D agonists in acute migraine with special reference to second generation agents.
    Acta neurologica Belgica, 1999, Volume: 99, Issue:2

    Topics: Acute Disease; Animals; Clinical Trials as Topic; Coronary Circulation; Coronary Vasospasm; Drug Design; Drug Interactions; Humans; Inactivation, Metabolic; Indoles; Meninges; Migraine Disorders; Molecular Structure; Nociceptors; Oxazoles; Oxazolidinones; Piperidines; Propranolol; Pyrrolidines; Randomized Controlled Trials as Topic; Rats; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Receptors, Serotonin; Recurrence; Serotonin Receptor Agonists; Structure-Activity Relationship; Sumatriptan; Treatment Outcome; Triazoles; Tryptamines; Vasoconstrictor Agents

1999
Rizatriptan: a review of its efficacy in the management of migraine.
    Drugs, 1999, Volume: 58, Issue:4

    Topics: Administration, Oral; Clinical Trials as Topic; Humans; Migraine Disorders; Serotonin Receptor Agonists; Sumatriptan; Time Factors; Triazoles; Tryptamines

1999
The scientific basis of medication choice in symptomatic migraine treatment.
    The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques, 1999, Volume: 26 Suppl 3

    Topics: Acute Disease; Choice Behavior; Dose-Response Relationship, Drug; Humans; Indoles; Migraine Disorders; Models, Biological; Oxazoles; Oxazolidinones; Piperidines; Serotonin Receptor Agonists; Severity of Illness Index; Sumatriptan; Triazoles; Tryptamines

1999
Newer intranasal migraine medications.
    American family physician, 2000, Jan-01, Volume: 61, Issue:1

    Topics: Administration, Intranasal; Administration, Oral; Analgesics, Non-Narcotic; Clinical Trials as Topic; Dihydroergotamine; Half-Life; Humans; Indoles; Migraine Disorders; Oxazoles; Oxazolidinones; Piperidines; Recurrence; Serotonin Receptor Agonists; Sumatriptan; Triazoles; Tryptamines

2000
[Rizatriptan].
    Neurologia (Barcelona, Spain), 2000, Volume: 15, Issue:1

    Topics: Dose-Response Relationship, Drug; Drug Tolerance; Humans; Migraine Disorders; Serotonin Receptor Agonists; Triazoles; Tryptamines

2000
Current and emerging second-generation triptans in acute migraine therapy: a comparative review.
    Journal of clinical pharmacology, 2000, Volume: 40, Issue:7

    Topics: Acute Disease; Carbazoles; Humans; Indoles; Migraine Disorders; Oxazoles; Oxazolidinones; Piperidines; Pyrrolidines; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Receptors, Serotonin; Serotonin Receptor Agonists; Triazoles; Tryptamines

2000
Rizatriptan in the treatment of migraine.
    Clinical therapeutics, 1999, Volume: 21, Issue:11

    Topics: Administration, Oral; Dose-Response Relationship, Drug; Humans; Migraine Disorders; Randomized Controlled Trials as Topic; Safety; Serotonin Receptor Agonists; Triazoles; Tryptamines

1999
Pharmacology and potential mechanisms of action of rizatriptan.
    Cephalalgia : an international journal of headache, 2000, Volume: 20 Suppl 1

    Topics: Brain; Humans; Migraine Disorders; Muscle, Smooth, Vascular; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Receptors, Serotonin; Serotonin Receptor Agonists; Synaptic Transmission; Triazoles; Trigeminal Nerve; Tryptamines

2000
Rizatriptan in acute treatment of migraine: update on new comparative data.
    Cephalalgia : an international journal of headache, 2000, Volume: 20 Suppl 1

    Topics: Acute Disease; Clinical Trials as Topic; Humans; Migraine Disorders; Serotonin Receptor Agonists; Treatment Outcome; Triazoles; Tryptamines

2000
Safety and tolerability of rizatriptan.
    Cephalalgia : an international journal of headache, 2000, Volume: 20 Suppl 1

    Topics: Adverse Drug Reaction Reporting Systems; Clinical Trials as Topic; Humans; Migraine Disorders; Serotonin Receptor Agonists; Triazoles; Tryptamines

2000
Mechanisms of action of serotonin 5-HT1B/D agonists: insights into migraine pathophysiology using rizatriptan.
    Neurology, 2000, Volume: 55, Issue:9 Suppl 2

    Topics: Humans; Migraine Disorders; Serotonin Receptor Agonists; Triazoles; Tryptamines

2000
The use of rizatriptan in the treatment of acute, multiple migraine attacks.
    Neurology, 2000, Volume: 55, Issue:9 Suppl 2

    Topics: Acute Disease; Humans; Migraine Disorders; Recurrence; Serotonin Receptor Agonists; Triazoles; Tryptamines

2000
Impact of migraine and migraine therapy on productivity and quality of life.
    Neurology, 2000, Volume: 55, Issue:9 Suppl 2

    Topics: Humans; Migraine Disorders; Quality of Life; Serotonin Receptor Agonists; Surveys and Questionnaires; Triazoles; Tryptamines

2000
New abortive agents for the treatment of migraine.
    Advances in internal medicine, 2001, Volume: 46

    Topics: Clinical Trials as Topic; Female; Humans; Indoles; Male; Migraine Disorders; Oxazolidinones; Piperidines; Prognosis; Recurrence; Serotonin Receptor Agonists; Severity of Illness Index; Sumatriptan; Treatment Outcome; Triazoles; Tryptamines

2001
Evidence-based analysis of a migraine treatment drug comparison trial.
    Cephalalgia : an international journal of headache, 2000, Volume: 20 Suppl 2

    Topics: Adult; Clinical Trials as Topic; Evidence-Based Medicine; Female; Humans; Migraine Disorders; Sumatriptan; Triazoles; Tryptamines

2000
[Current topics: expectation for new triptans].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 2001, Apr-10, Volume: 90, Issue:4

    Topics: Humans; Indoles; Migraine Disorders; Oxazolidinones; Piperidines; Pyrrolidines; Serotonin Receptor Agonists; Sumatriptan; Triazoles; Tryptamines

2001
Meta-analysis of rizatriptan efficacy in randomized controlled clinical trials.
    Cephalalgia : an international journal of headache, 2001, Volume: 21, Issue:2

    Topics: Adult; Clinical Trials, Phase III as Topic; Double-Blind Method; Female; Humans; Male; Migraine Disorders; Randomized Controlled Trials as Topic; Treatment Outcome; Triazoles; Tryptamines

2001
Establishing a standard of speed for assessing the efficacy of the serotonin(1B/1D) agonists (triptans).
    Archives of neurology, 2001, Volume: 58, Issue:7

    Topics: Analgesics, Non-Narcotic; Carbazoles; Clinical Trials as Topic; Humans; Indoles; Migraine Disorders; Oxazolidinones; Pain Measurement; Patient Satisfaction; Piperidines; Pyrrolidines; Serotonin Receptor Agonists; Sumatriptan; Time Factors; Treatment Outcome; Triazoles; Tryptamines

2001
Triptans are all different.
    Archives of neurology, 2001, Volume: 58, Issue:9

    Topics: Carbazoles; Headache; Humans; Indoles; Oxazolidinones; Pyrrolidines; Serotonin Receptor Agonists; Sumatriptan; Triazoles; Tryptamines

2001
What matters is not the differences between triptans, but the differences between patients.
    Archives of neurology, 2001, Volume: 58, Issue:9

    Topics: Humans; Migraine Disorders; Oxazolidinones; Serotonin Receptor Agonists; Sumatriptan; Triazoles; Tryptamines

2001
Comparison of rizatriptan and other triptans on stringent measures of efficacy.
    Neurology, 2001, Oct-23, Volume: 57, Issue:8

    Topics: Administration, Oral; Humans; Indoles; Migraine Disorders; Oxazolidinones; Patient Satisfaction; Piperidines; Randomized Controlled Trials as Topic; Retrospective Studies; Serotonin Receptor Agonists; Sumatriptan; Triazoles; Tryptamines

2001
Rizatriptan for acute migraine.
    The Cochrane database of systematic reviews, 2001, Issue:3

    Topics: Acute Disease; Humans; Migraine Disorders; Randomized Controlled Trials as Topic; Serotonin Receptor Agonists; Triazoles; Tryptamines

2001
Patient satisfaction with rizatriptan versus other triptans: direct head-to-head comparisons.
    International journal of clinical practice, 2001, Volume: 55, Issue:8

    Topics: Adolescent; Adult; Aged; Clinical Trials, Phase III as Topic; Double-Blind Method; Female; Humans; Male; Middle Aged; Migraine Disorders; Patient Satisfaction; Serotonin Receptor Agonists; Sumatriptan; Triazoles; Tryptamines

2001
Oral triptans (serotonin 5-HT(1B/1D) agonists) in acute migraine treatment: a meta-analysis of 53 trials.
    Lancet (London, England), 2001, Nov-17, Volume: 358, Issue:9294

    Topics: Acute Disease; Administration, Oral; Humans; Indoles; Migraine Disorders; Pyrrolidines; Randomized Controlled Trials as Topic; Recurrence; Serotonin Receptor Agonists; Severity of Illness Index; Treatment Outcome; Triazoles; Tryptamines

2001
Acute treatment of migraine and the role of triptans.
    Current neurology and neuroscience reports, 2001, Volume: 1, Issue:2

    Topics: Acute Disease; Blood Flow Velocity; Carbazoles; Clinical Trials as Topic; Drug Administration Routes; Female; Humans; Indoles; Male; Menstruation; Migraine Disorders; Oxazolidinones; Piperidines; Practice Guidelines as Topic; Pyrrolidines; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Receptors, Serotonin; Serotonin Receptor Agonists; Sumatriptan; Treatment Outcome; Triazoles; Tryptamines; Vasoconstriction; Vasoconstrictor Agents

2001
Rizatriptan: an update of its use in the management of migraine.
    Drugs, 2002, Volume: 62, Issue:10

    Topics: Administration, Oral; Adolescent; Adult; Animals; Biological Availability; Databases, Bibliographic; Humans; Migraine Disorders; Randomized Controlled Trials as Topic; Serotonin Receptor Agonists; Treatment Outcome; Triazoles; Tryptamines

2002
Mechanisms of action of the 5-HT1B/1D receptor agonists.
    Archives of neurology, 2002, Volume: 59, Issue:7

    Topics: Carbazoles; Humans; Indoles; Migraine Disorders; Oxazolidinones; Piperidines; Pyrrolidines; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Receptors, Serotonin; Serotonin Receptor Agonists; Sumatriptan; Triazoles; Tryptamines

2002
[Treatment of migraine in patients with hypertension and ischemic heart disease].
    Ideggyogyaszati szemle, 2002, Jan-20, Volume: 55, Issue:1-2

    Topics: Adjuvants, Pharmaceutic; Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal; Carbazoles; Contraindications; Dihydroergotamine; Dopamine Agonists; Ergotamine; Humans; Hypertension; Indoles; Migraine Disorders; Myocardial Ischemia; Oxazolidinones; Retrospective Studies; Serotonin Receptor Agonists; Sumatriptan; Triazoles; Tryptamines; Vasoconstrictor Agents

2002
Spotlight on rizatriptan in migraine.
    CNS drugs, 2002, Volume: 16, Issue:10

    Topics: Animals; Humans; Migraine Disorders; Randomized Controlled Trials as Topic; Serotonin Receptor Agonists; Treatment Outcome; Triazoles; Tryptamines

2002
Rizatriptan: pharmacological differences from sumatriptan and clinical results.
    Current medical research and opinion, 2001, Volume: 17 Suppl 1

    Topics: Administration, Oral; Humans; Migraine Disorders; Patient Satisfaction; Recurrence; Serotonin Receptor Agonists; Sumatriptan; Triazoles; Tryptamines

2001
Comparative aspects of triptans in treating migraine.
    Clinical cornerstone, 2001, Volume: 4, Issue:3

    Topics: Carbazoles; Cardiovascular Diseases; Humans; Indoles; Migraine Disorders; Oxazolidinones; Patient Satisfaction; Piperidines; Pyrrolidines; Serotonin Receptor Agonists; Sumatriptan; Treatment Outcome; Triazoles; Tryptamines

2001
Newer formulations of the triptans: advances in migraine management.
    Drugs, 2003, Volume: 63, Issue:21

    Topics: Analgesics; Area Under Curve; Chemistry, Pharmaceutical; Humans; Migraine Disorders; Oxazolidinones; Randomized Controlled Trials as Topic; Serotonin Receptor Agonists; Treatment Outcome; Triazoles; Tryptamines

2003
Triptans for treatment of acute pediatric migraine: a systematic literature review.
    Pediatric neurology, 2003, Volume: 29, Issue:5

    Topics: Acute Disease; Administration, Intranasal; Administration, Oral; Child; Clinical Trials as Topic; Humans; Migraine Disorders; Randomized Controlled Trials as Topic; Serotonin Receptor Agonists; Sumatriptan; Triazoles; Tryptamines

2003
Naratriptan for the treatment of acute migraine: meta-analysis of randomised controlled trials.
    Pharmacoepidemiology and drug safety, 2004, Volume: 13, Issue:2

    Topics: Dose-Response Relationship, Drug; Humans; Indoles; Migraine Disorders; Oxazolidinones; Piperidines; Randomized Controlled Trials as Topic; Serotonin Receptor Agonists; Sumatriptan; Triazoles; Tryptamines

2004
[Recent progress in therapy for migraine headache].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 2004, Feb-10, Volume: 93, Issue:2

    Topics: Anticonvulsants; Botulinum Toxins; Calcitonin Gene-Related Peptide; Central Nervous System; Clinical Trials as Topic; Drug Design; Fructose; Humans; Indoles; Meta-Analysis as Topic; Migraine Disorders; Pain; Piperidines; Pyrrolidines; Serotonin Receptor Agonists; Signal Transduction; Sumatriptan; Topiramate; Triazoles; Trigeminal Nerve; Tryptamines; Vasodilation

2004
A review of rizatriptan, a quick and consistent 5-HT1B/1D agonist for the acute treatment of migraine.
    Expert opinion on pharmacotherapy, 2004, Volume: 5, Issue:3

    Topics: Acute Disease; Administration, Oral; Clinical Trials as Topic; Drug Interactions; Humans; Migraine Disorders; Serotonin 5-HT1 Receptor Agonists; Triazoles; Tryptamines

2004
[Rizatriptan (Maxalt), a new entity of triptan for migraine: pharmacology and therapeutic relevance].
    Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 2004, Volume: 123, Issue:4

    Topics: Clinical Trials as Topic; Humans; Meningeal Arteries; Migraine Disorders; Quality of Life; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Serotonin 5-HT1 Receptor Agonists; Tablets; Triazoles; Trigeminal Nerve; Tryptamines

2004
[Meta-analysis of triptan treatment in migraine].
    No to shinkei = Brain and nerve, 2004, Volume: 56, Issue:9

    Topics: Carbazoles; Evidence-Based Medicine; Humans; Indoles; Migraine Disorders; Oxazolidinones; Piperidines; Pyrrolidines; Receptor, Serotonin, 5-HT1D; Serotonin Receptor Agonists; Sumatriptan; Triazoles; Tryptamines

2004
[Side effects of triptans].
    No to shinkei = Brain and nerve, 2004, Volume: 56, Issue:9

    Topics: Central Nervous System; Dose-Response Relationship, Drug; Humans; Indoles; Migraine Disorders; Nausea; Oxazolidinones; Pyrrolidines; Receptor, Serotonin, 5-HT1D; Serotonin Receptor Agonists; Sleep Stages; Sumatriptan; Triazoles; Tryptamines; Vomiting

2004
Migraine headache.
    Clinical evidence, 2003, Issue:10

    Topics: Acute Disease; Adult; Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal; Child; Diclofenac; Drug Therapy, Combination; Ergotamine; Humans; Ibuprofen; Indoles; Migraine Disorders; Naproxen; ortho-Aminobenzoates; Oxazolidinones; Piperidines; Pyrrolidines; Salicylates; Serotonin Receptor Agonists; Sumatriptan; Triazoles; Tryptamines

2003
Migraine headache.
    Clinical evidence, 2004, Issue:11

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Ergotamine; Humans; Ibuprofen; Indoles; Migraine Disorders; Naproxen; ortho-Aminobenzoates; Oxazolidinones; Piperidines; Pyrrolidines; Salicylates; Sumatriptan; Triazoles; Tryptamines

2004
Cost-effectiveness analysis of rizatriptan and sumatriptan versus Cafergot in the acute treatment of migraine.
    CNS drugs, 2005, Volume: 19, Issue:7

    Topics: Caffeine; Cost-Benefit Analysis; Drug Combinations; Drug Therapy, Combination; Economics, Pharmaceutical; Ergotamine; Humans; Migraine Disorders; Serotonin Receptor Agonists; Sumatriptan; Triazoles; Tryptamines

2005
The treatment of pediatric migraine.
    Pediatric annals, 2005, Volume: 34, Issue:6

    Topics: Adrenergic beta-Antagonists; Anticonvulsants; Antidepressive Agents; Antiemetics; Biofeedback, Psychology; Calcium Channel Blockers; Child; Complementary Therapies; Contraindications; Cyproheptadine; Diet; Ergot Alkaloids; Humans; Migraine Disorders; Migraine without Aura; Oxazolidinones; Serotonin Receptor Agonists; Sumatriptan; Triazoles; Tryptamines

2005
Rizatriptan in migraine.
    Expert review of neurotherapeutics, 2005, Volume: 5, Issue:5

    Topics: Dose-Response Relationship, Drug; Drug Tolerance; Drug-Related Side Effects and Adverse Reactions; Expert Testimony; Humans; Meta-Analysis as Topic; Migraine Disorders; Serotonin Receptor Agonists; Triazoles; Tryptamines

2005
Rizatriptan: a pharmacoeconomic review of its use in the acute treatment of migraine.
    PharmacoEconomics, 2005, Volume: 23, Issue:12

    Topics: Economics, Pharmaceutical; Humans; Migraine Disorders; Serotonin 5-HT1 Receptor Agonists; Serotonin Receptor Agonists; Triazoles; Tryptamines

2005
[Triptanes in the treatment of migraine. A review based on three Cochrane reviews].
    Ugeskrift for laeger, 2006, May-08, Volume: 168, Issue:19

    Topics: Acute Disease; Administration, Oral; Dose-Response Relationship, Drug; Humans; Migraine Disorders; Pyrrolidines; Serotonin Receptor Agonists; Sumatriptan; Triazoles; Tryptamines

2006
Acute treatment of paediatric migraine: a meta-analysis of efficacy.
    Journal of paediatrics and child health, 2008, Volume: 44, Issue:1-2

    Topics: Acetaminophen; Adolescent; Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal; Child; Dihydroergotamine; Drug Evaluation; Humans; Ibuprofen; Migraine Disorders; Oxazolidinones; Placebos; Randomized Controlled Trials as Topic; Serotonin Receptor Agonists; Sumatriptan; Triazoles; Tryptamines

2008
A review of the 5-HT1B/1D agonist rizatriptan: update on recent research and implications for the future.
    Expert opinion on pharmacotherapy, 2008, Volume: 9, Issue:6

    Topics: Adult; Child; Drug Therapy, Combination; Humans; Migraine Disorders; Randomized Controlled Trials as Topic; Serotonin 5-HT1 Receptor Agonists; Time Factors; Triazoles; Tryptamines

2008
Acute treatment and prevention of menstrually related migraine headache: evidence-based review.
    Neurology, 2008, Apr-22, Volume: 70, Issue:17

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Carbazoles; Double-Blind Method; Estrogens; Evidence-Based Medicine; Female; Humans; Male; Mefenamic Acid; Menstruation; Meta-Analysis as Topic; Migraine Disorders; Randomized Controlled Trials as Topic; Serotonin Receptor Agonists; Sumatriptan; Treatment Outcome; Triazoles; Tryptamines

2008
Ten years of rizatriptan: from development to clinical science and future directions.
    Headache, 2009, Volume: 49 Suppl 1

    Topics: Animals; Drug Design; Drug Evaluation; Drug Therapy; History, 20th Century; History, 21st Century; Humans; Migraine Disorders; Randomized Controlled Trials as Topic; Serotonin Receptor Agonists; Triazoles; Tryptamines

2009
Acute migraine treatment with rizatriptan in real world settings - focusing on treatment strategy, effectiveness, and behavior.
    Headache, 2009, Volume: 49 Suppl 1

    Topics: Clinical Trials as Topic; Humans; Migraine Disorders; Outcome Assessment, Health Care; Patient Selection; Serotonin Receptor Agonists; Triazoles; Tryptamines

2009
Efficacy and tolerability of rizatriptan 10 mg compared with sumatriptan 100 mg: an evidence-based analysis.
    Expert review of neurotherapeutics, 2010, Volume: 10, Issue:4

    Topics: Double-Blind Method; Evidence-Based Medicine; Humans; Meta-Analysis as Topic; Migraine Disorders; Patient Preference; Randomized Controlled Trials as Topic; Serotonin Receptor Agonists; Sumatriptan; Triazoles; Tryptamines

2010
Total migraine freedom, a potential primary endpoint to assess acute treatment in migraine: comparison to the current FDA requirement using the complete rizatriptan study database.
    Headache, 2011, Volume: 51, Issue:3

    Topics: Adult; Clinical Trials, Phase III as Topic; Databases, Factual; Endpoint Determination; Female; Humans; Male; Migraine Disorders; Serotonin Receptor Agonists; Treatment Outcome; Triazoles; Tryptamines; United States; United States Food and Drug Administration

2011
Types of colitis based on histology.
    Disease-a-month : DM, 2011, Volume: 57, Issue:9

    Topics: Angiogenesis Inhibitors; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antigens, CD; Antineoplastic Agents; Bevacizumab; Caustics; Colitis; Colitis, Collagenous; Colitis, Ischemic; Colitis, Lymphocytic; Colitis, Ulcerative; Colon; CTLA-4 Antigen; Cyclooxygenase 2 Inhibitors; Diclofenac; Enterocolitis, Necrotizing; Humans; Plants, Medicinal; Serotonin Receptor Agonists; Tomography, X-Ray Computed; Triazoles; Tryptamines

2011
Sumatriptan (intranasal route of administration) for acute migraine attacks in adults.
    The Cochrane database of systematic reviews, 2012, Feb-15, Issue:2

    Topics: Acute Disease; Administration, Intranasal; Adult; Dihydroergotamine; Female; Humans; Male; Migraine Disorders; Pain Management; Randomized Controlled Trials as Topic; Serotonin 5-HT1 Receptor Agonists; Sumatriptan; Triazoles; Tryptamines

2012
Efficacy of frovatriptan and other triptans in the treatment of acute migraine of hypertensive and normotensive subjects: a review of randomized studies.
    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2013, Volume: 34 Suppl 1

    Topics: Carbazoles; Cross-Over Studies; Double-Blind Method; Humans; Hypertension; Migraine Disorders; Oxazolidinones; Randomized Controlled Trials as Topic; Serotonin Receptor Agonists; Triazoles; Tryptamines

2013
The efficacy of triptans in childhood and adolescence migraine.
    Current pain and headache reports, 2013, Volume: 17, Issue:7

    Topics: Adolescent; Analgesics; Child; Cross-Over Studies; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Germany; Humans; Male; Migraine Disorders; Oxazolidinones; Sumatriptan; Treatment Outcome; Triazoles; Tryptamines

2013
[Rizatriptan: experience after 15 years of clinical use].
    Revista de neurologia, 2013, Dec-16, Volume: 57, Issue:12

    Topics: Adolescent; Adult; Biological Availability; Child; Clinical Trials as Topic; Drug Approval; Humans; Migraine Disorders; Patient Acceptance of Health Care; Serotonin; Serotonin 5-HT1 Receptor Agonists; Treatment Outcome; Triazoles; Tryptamines; Vasoconstrictor Agents

2013
Efficacy, safety, and tolerability of telcagepant in the treatment of acute migraine: a meta-analysis.
    Pain practice : the official journal of World Institute of Pain, 2015, Volume: 15, Issue:2

    Topics: Acute Disease; Azepines; Calcitonin Gene-Related Peptide Receptor Antagonists; Humans; Imidazoles; Migraine Disorders; Oxazolidinones; Serotonin 5-HT1 Receptor Agonists; Treatment Outcome; Triazoles; Tryptamines

2015
Oral triptans in children and adolescents: an update.
    Current pain and headache reports, 2015, Volume: 19, Issue:3

    Topics: Acetaminophen; Administration, Oral; Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Child; Dose-Response Relationship, Drug; Humans; Migraine Disorders; Randomized Controlled Trials as Topic; Treatment Outcome; Triazoles; Tryptamines; United States; United States Food and Drug Administration

2015
Efficacy of frovatriptan as compared to other triptans in migraine with aura.
    The journal of headache and pain, 2015, Volume: 16

    Topics: Adult; Carbazoles; Female; Humans; Male; Middle Aged; Migraine with Aura; Oxazolidinones; Randomized Controlled Trials as Topic; Treatment Outcome; Triazoles; Tryptamines

2015
Spotlight on frovatriptan: a review of its efficacy in the treatment of migraine.
    Drug design, development and therapy, 2016, Volume: 10

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Carbazoles; Cross-Over Studies; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Italy; Ketoprofen; Male; Migraine Disorders; Randomized Controlled Trials as Topic; Triazoles; Tromethamine; Tryptamines

2016
Network meta-analysis of migraine disorder treatment by NSAIDs and triptans.
    The journal of headache and pain, 2016, Volume: 17, Issue:1

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Humans; Ibuprofen; Migraine Disorders; Oxazolidinones; Pyrrolidines; Randomized Controlled Trials as Topic; Sumatriptan; Treatment Outcome; Triazoles; Tryptamines

2016
Aquaporin-Targeted Therapeutics: State-of-the-Field.
    Advances in experimental medicine and biology, 2017, Volume: 969

    Topics: Animals; Aquaporin 4; Biological Transport; Brain Edema; Gene Expression Regulation; Humans; Molecular Targeted Therapy; Neuromyelitis Optica; Osmolar Concentration; Osmotic Pressure; Protein Isoforms; Sumatriptan; Thiadiazoles; Triazoles; Tryptamines; Water

2017
[Placebo and nocebo : How can they be used or avoided?]
    Der Internist, 2017, Volume: 58, Issue:10

    Topics: Analgesics; Ethics, Medical; Humans; Migraine Disorders; Nocebo Effect; Physician-Patient Relations; Placebo Effect; Placebos; Risk Factors; Triazoles; Tryptamines

2017
Rizatriptan-Induced Colonic Ischemia: A Case Report and Literature Review.
    The American journal of gastroenterology, 2018, Volume: 113, Issue:1

    Topics: Colectomy; Colonic Diseases; Computed Tomography Angiography; Humans; Infarction; Male; Mesenteric Ischemia; Middle Aged; Migraine Disorders; Serotonin Receptor Agonists; Triazoles; Tryptamines

2018
Pediatric and Adolescent Headache.
    Continuum (Minneapolis, Minn.), 2018, Volume: 24, Issue:4, Headach

    Topics: Adolescent; Child; Disease Management; Headache; Humans; Pediatrics; Serotonin Receptor Agonists; Triazoles; Tryptamines

2018

Trials

99 trial(s) available for triazoles and rizatriptan

ArticleYear
Pilot study of MK-462 in migraine.
    Cephalalgia : an international journal of headache, 1996, Volume: 16, Issue:2

    Topics: Adult; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Migraine Disorders; Pain Measurement; Pilot Projects; Serotonin Receptor Agonists; Triazoles; Tryptamines

1996
Rizatriptan vs sumatriptan in the acute treatment of migraine. A placebo-controlled, dose-ranging study. Dutch/US Rizatriptan Study Group.
    Archives of neurology, 1996, Volume: 53, Issue:11

    Topics: Adult; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Migraine Disorders; Serotonin Receptor Agonists; Sumatriptan; Triazoles; Tryptamines

1996
Pharmacokinetics and food interaction of MK-462 in healthy males.
    Biopharmaceutics & drug disposition, 1996, Volume: 17, Issue:1

    Topics: Absorption; Administration, Oral; Adolescent; Adult; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Evaluation Studies as Topic; Food; Humans; Infusions, Intravenous; Male; Placebos; Serotonin Receptor Agonists; Triazoles; Tryptamines

1996
Initial human experience with MK-462 (rizatriptan): a novel 5-HT1D agonist.
    British journal of clinical pharmacology, 1997, Volume: 43, Issue:1

    Topics: Administration, Oral; Adult; Analysis of Variance; Blood Pressure; Double-Blind Method; Heart Rate; Humans; Male; Migraine Disorders; Serotonin Receptor Agonists; Sumatriptan; Triazoles; Tryptamines

1997
Double-blind, placebo-controlled, dose-finding study of rizatriptan (MK-462) in the acute treatment of migraine.
    Cephalalgia : an international journal of headache, 1997, Volume: 17, Issue:6

    Topics: Acute Disease; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Logistic Models; Male; Migraine Disorders; Regression Analysis; Serotonin Receptor Agonists; Triazoles; Tryptamines

1997
Improvement in migraine-specific quality of life in a clinical trial of rizatriptan.
    Cephalalgia : an international journal of headache, 1997, Volume: 17, Issue:8

    Topics: Adult; Analysis of Variance; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Migraine Disorders; Quality of Life; Reproducibility of Results; Serotonin Receptor Agonists; Surveys and Questionnaires; Treatment Outcome; Triazoles; Tryptamines

1997
Rizatriptan (MAXALT) for the acute treatment of migraine and migraine recurrence. A placebo-controlled, outpatient study. Rizatriptan 022 Study Group.
    Headache, 1998, Volume: 38, Issue:4

    Topics: Acute Disease; Adolescent; Adult; Aged; Double-Blind Method; Female; Humans; Male; Middle Aged; Migraine Disorders; Recurrence; Serotonin Receptor Agonists; Triazoles; Tryptamines

1998
A placebo-controlled crossover study of rizatriptan in the treatment of multiple migraine attacks. Rizatriptan Multiple Attack Study Group.
    Neurology, 1998, Volume: 51, Issue:3

    Topics: Administration, Oral; Adolescent; Adult; Aged; Cross-Over Studies; Female; Humans; Male; Middle Aged; Migraine Disorders; Patient Satisfaction; Serotonin Receptor Agonists; Treatment Outcome; Triazoles; Tryptamines

1998
Pharmacokinetics and tolerability of intravenous rizatriptan in healthy females.
    Biopharmaceutics & drug disposition, 1998, Volume: 19, Issue:9

    Topics: Adult; Analysis of Variance; Cross-Over Studies; Dizziness; Female; Humans; Injections, Intravenous; Migraine Disorders; Serotonin Receptor Agonists; Tachycardia; Triazoles; Tryptamines

1998
Pharmacokinetics and tolerability of oral rizatriptan in healthy male and female volunteers.
    British journal of clinical pharmacology, 1999, Volume: 47, Issue:4

    Topics: Administration, Oral; Animals; Cross-Over Studies; Female; Male; Mice; Serotonin Receptor Agonists; Sex Factors; Triazoles; Tryptamines

1999
Validation of a migraine work and productivity loss questionnaire for use in migraine studies.
    Cephalalgia : an international journal of headache, 1999, Volume: 19, Issue:5

    Topics: Absenteeism; Adult; Disability Evaluation; Female; Humans; Male; Middle Aged; Migraine Disorders; Reproducibility of Results; Serotonin Receptor Agonists; Sickness Impact Profile; Triazoles; Tryptamines

1999
Efficacy and safety of rizatriptan wafer for the acute treatment of migraine. Rizatriptan Wafer Protocol 049 Study Group.
    Cephalalgia : an international journal of headache, 1999, Volume: 19, Issue:5

    Topics: Administration, Oral; Adolescent; Adult; Aged; Dosage Forms; Double-Blind Method; Female; Humans; Male; Middle Aged; Migraine Disorders; Pain Measurement; Serotonin Receptor Agonists; Treatment Outcome; Triazoles; Tryptamines

1999
The effects of moclobemide on the pharmacokinetics of the 5-HT1B/1D agonist rizatriptan in healthy volunteers.
    British journal of clinical pharmacology, 1999, Volume: 48, Issue:2

    Topics: Adult; Area Under Curve; Benzamides; Biotransformation; Blood Pressure; Cross-Over Studies; Double-Blind Method; Female; Half-Life; Humans; Male; Methoxyhydroxyphenylglycol; Moclobemide; Monoamine Oxidase Inhibitors; Oxazoles; Oxazolidinones; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Receptors, Serotonin; Serotonin Receptor Agonists; Sumatriptan; Triazoles; Tryptamines

1999
Comparison of rizatriptan 10 mg vs. naratriptan 2.5 mg in migraine.
    European neurology, 1999, Volume: 42, Issue:3

    Topics: Adult; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Indoles; Male; Middle Aged; Migraine Disorders; Piperidines; Recurrence; Serotonin Receptor Agonists; Treatment Outcome; Triazoles; Tryptamines

1999
Rizatriptan, a novel 5-HT1B/1D agonist for migraine: single- and multiple-dose tolerability and pharmacokinetics in healthy subjects.
    Journal of clinical pharmacology, 2000, Volume: 40, Issue:1

    Topics: Adult; Blood Pressure; Double-Blind Method; Female; Humans; Male; Middle Aged; Placebos; Serotonin Receptor Agonists; Time Factors; Triazoles; Tryptamines

2000
A double-blind, placebo-controlled evaluation of the effect of oral doses of rizatriptan 10 mg on oral contraceptive pharmacokinetics in healthy female volunteers.
    Journal of clinical pharmacology, 2000, Volume: 40, Issue:3

    Topics: Administration, Oral; Adolescent; Adult; Contraceptives, Oral, Combined; Cross-Over Studies; Double-Blind Method; Drug Administration Schedule; Drug Antagonism; Drug Combinations; Female; Humans; Mestranol; Norethindrone; Placebos; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Receptors, Serotonin; Serotonin Receptor Agonists; Triazoles; Tryptamines

2000
Treatment of nonresponders to oral sumatriptan with zolmitriptan and rizatriptan: a comparative open trial.
    Headache, 2000, Volume: 40, Issue:6

    Topics: Administration, Oral; Cross-Over Studies; Drug Resistance; Humans; Migraine Disorders; Oxazoles; Oxazolidinones; Retreatment; Serotonin Receptor Agonists; Sumatriptan; Triazoles; Tryptamines; Vasoconstrictor Agents

2000
Comparison of rizatriptan 10 mg vs. zolmitriptan 2.5 mg in the acute treatment of migraine. Rizatriptan-Zolmitriptan Study Group.
    Cephalalgia : an international journal of headache, 2000, Volume: 20, Issue:5

    Topics: Adult; Disability Evaluation; Double-Blind Method; Female; Humans; Male; Migraine Disorders; Oxazolidinones; Quality of Life; Recurrence; Retreatment; Serotonin Receptor Agonists; Time Factors; Triazoles; Tryptamines

2000
Vascular effects of 5-HT1B/1D-receptor agonists in patients with migraine headaches.
    Clinical pharmacology and therapeutics, 2000, Volume: 68, Issue:4

    Topics: Adult; Analysis of Variance; Blood Flow Velocity; Blood Pressure; Brachial Artery; Carotid Artery, Common; Cross-Over Studies; Double-Blind Method; Female; Humans; Male; Middle Aged; Migraine Disorders; Oxazolidinones; Serotonin Receptor Agonists; Sumatriptan; Temporal Arteries; Triazoles; Tryptamines; Ultrasonography; Vascular Resistance; Vasoconstrictor Agents; Vasodilation

2000
Rizatriptan wafer--sublingual vs. placebo at the onset of acute migraine.
    Cephalalgia : an international journal of headache, 2000, Volume: 20, Issue:6

    Topics: Acute Disease; Administration, Oral; Administration, Sublingual; Analgesics; Double-Blind Method; Flavoring Agents; Humans; Mentha piperita; Patient Acceptance of Health Care; Placebo Effect; Plant Extracts; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Receptors, Serotonin; Serotonin Receptor Agonists; Time Factors; Treatment Outcome; Triazoles; Tryptamines

2000
Within-patient consistency of response of rizatriptan for treating migraine.
    Neurology, 2000, Nov-28, Volume: 55, Issue:10

    Topics: Adolescent; Adult; Aged; Double-Blind Method; Female; Humans; Male; Middle Aged; Migraine Disorders; Triazoles; Tryptamines

2000
Work and productivity loss in the rizatriptan multiple attack study.
    Cephalalgia : an international journal of headache, 2000, Volume: 20, Issue:9

    Topics: Absenteeism; Adult; Efficiency; Female; Humans; Male; Middle Aged; Migraine Disorders; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Serotonin Receptor Agonists; Surveys and Questionnaires; Triazoles; Tryptamines; Work

2000
Efficacy and tolerability of rizatriptan 10 mg in migraine: experience with 70 527 patient episodes.
    Headache, 2001, Volume: 41, Issue:3

    Topics: Adult; Female; Humans; Male; Migraine Disorders; Recurrence; Serotonin Receptor Agonists; Time Factors; Treatment Outcome; Triazoles; Tryptamines

2001
Comparison of preference for rizatriptan 10-mg wafer versus sumatriptan 50-mg tablet in migraine.
    European neurology, 2001, Volume: 45, Issue:4

    Topics: Administration, Oral; Adolescent; Adult; Aged; Cross-Over Studies; Female; Humans; Male; Middle Aged; Migraine Disorders; Patient Satisfaction; Serotonin Receptor Agonists; Sumatriptan; Tablets; Triazoles; Tryptamines

2001
A comparison of visual analog scale and categorical ratings of headache pain in a randomized controlled clinical trial with migraine patients.
    Pain, 2001, Volume: 93, Issue:2

    Topics: Adolescent; Adult; Aged; Double-Blind Method; Female; Humans; Male; Middle Aged; Migraine Disorders; Pain Measurement; Serotonin Agents; Sumatriptan; Treatment Outcome; Triazoles; Tryptamines; Vasoconstrictor Agents

2001
Influence of beta-adrenoceptor antagonists on the pharmacokinetics of rizatriptan, a 5-HT1B/1D agonist: differential effects of propranolol, nadolol and metoprolol.
    British journal of clinical pharmacology, 2001, Volume: 52, Issue:1

    Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Biological Availability; Cardiovascular System; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; In Vitro Techniques; Male; Metoprolol; Middle Aged; Nadolol; Propranolol; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Receptors, Serotonin; Serotonin Receptor Agonists; Triazoles; Tryptamines

2001
Long-term efficacy and tolerability of rizatriptan wafers in migraine.
    MedGenMed : Medscape general medicine, 2001, Jun-01, Volume: 3, Issue:3

    Topics: Adult; Double-Blind Method; Female; Humans; Male; Migraine Disorders; Pain Measurement; Serotonin Receptor Agonists; Treatment Outcome; Triazoles; Tryptamines

2001
Lack of pharmacokinetic and pharmacodynamic interaction between rizatriptan and paroxetine.
    Journal of clinical pharmacology, 1999, Volume: 39, Issue:2

    Topics: Adult; Affect; Analysis of Variance; Area Under Curve; Blood Pressure; Body Temperature; Confidence Intervals; Cross-Over Studies; Double-Blind Method; Drug Interactions; Female; Heart Rate; Humans; Male; Paroxetine; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists; Statistics, Nonparametric; Triazoles; Tryptamines

1999
Preference comparison of rizatriptan ODT 10-mg and sumatriptan 50-mg tablet in migraine.
    Headache, 2001, Volume: 41, Issue:8

    Topics: Adult; Cross-Over Studies; Female; Humans; Male; Migraine Disorders; Serotonin Receptor Agonists; Sumatriptan; Tablets; Treatment Outcome; Triazoles; Tryptamines; Vasoconstrictor Agents

2001
Pharmacokinetics of rizatriptan in healthy elderly subjects.
    International journal of clinical pharmacology and therapeutics, 2001, Volume: 39, Issue:10

    Topics: Adult; Aged; Aging; Analysis of Variance; Area Under Curve; Chromatography, High Pressure Liquid; Double-Blind Method; Female; Half-Life; Humans; Male; Metabolic Clearance Rate; Serotonin Receptor Agonists; Triazoles; Tryptamines

2001
Clinical features of withdrawal headache following overuse of triptans and other headache drugs.
    Neurology, 2001, Nov-13, Volume: 57, Issue:9

    Topics: Adult; Analgesics; Drug Therapy, Combination; Ergotamine; Female; Headache; Humans; Indoles; Male; Middle Aged; Oxazolidinones; Piperidines; Prospective Studies; Substance Withdrawal Syndrome; Sumatriptan; Triazoles; Tryptamines; Vasoconstrictor Agents

2001
Rizatriptan 5 mg for the acute treatment of migraine in adolescents: a randomized, double-blind, placebo-controlled study.
    Headache, 2002, Volume: 42, Issue:1

    Topics: Adolescent; Child; Double-Blind Method; Female; Humans; Male; Migraine Disorders; Placebos; Serotonin Receptor Agonists; Time Factors; Treatment Outcome; Triazoles; Tryptamines

2002
CNS effects of sumatriptan and rizatriptan in healthy female volunteers.
    Cephalalgia : an international journal of headache, 2002, Volume: 22, Issue:4

    Topics: Adult; Affect; Brain; Cognition; Cross-Over Studies; Dizziness; Double-Blind Method; Electroencephalography; Eye Movements; Female; Headache; Humans; Hypnotics and Sedatives; Nerve Tissue Proteins; Neuropsychological Tests; Postural Balance; Reaction Time; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Receptors, Serotonin; Recognition, Psychology; Reference Values; Serotonin Receptor Agonists; Sumatriptan; Temazepam; Triazoles; Tryptamines

2002
Rizatriptan combined with rofecoxib vs. rizatriptan for the acute treatment of migraine: an open label pilot study.
    Cephalalgia : an international journal of headache, 2002, Volume: 22, Issue:4

    Topics: Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase Inhibitors; Drug Therapy, Combination; Female; Humans; Lactones; Male; Middle Aged; Migraine Disorders; Nausea; Pilot Projects; Prospective Studies; Recurrence; Serotonin Receptor Agonists; Sulfones; Triazoles; Tryptamines

2002
The effect of rizatriptan, ergotamine, and their combination on human peripheral arteries: a double-blind, placebo-controlled, crossover study in normal subjects.
    British journal of clinical pharmacology, 2002, Volume: 54, Issue:1

    Topics: Adult; Arteries; Cross-Over Studies; Double-Blind Method; Drug Combinations; Ergotamine; Heart Rate; Humans; Male; Migraine Disorders; Serotonin Receptor Agonists; Triazoles; Tryptamines; Vasoconstriction; Vasoconstrictor Agents

2002
Determinants of migraine-specific quality of life.
    Cephalalgia : an international journal of headache, 2002, Volume: 22, Issue:8

    Topics: Adult; Humans; Migraine Disorders; Multicenter Studies as Topic; Quality of Life; Randomized Controlled Trials as Topic; Serotonin Receptor Agonists; Time Factors; Triazoles; Tryptamines

2002
Crossover comparison of efficacy and preference for rizatriptan 10 mg versus ergotamine/caffeine in migraine.
    European neurology, 2003, Volume: 49, Issue:1

    Topics: Adolescent; Adult; Aged; Caffeine; Cross-Over Studies; Double-Blind Method; Drug Combinations; Ergotamine; Female; Humans; Male; Middle Aged; Migraine Disorders; Pain Measurement; Patient Satisfaction; Serotonin Receptor Agonists; Triazoles; Tryptamines

2003
[Satisfaction and recovery of normal activity with rizatriptan 10 mg. Results from the open, prospective, observational 4M study].
    Neurologia (Barcelona, Spain), 2002, Volume: 17, Issue:10

    Topics: Adult; Female; Humans; Male; Middle Aged; Migraine Disorders; Pain Measurement; Patient Satisfaction; Prospective Studies; Serotonin Receptor Agonists; Time Factors; Treatment Outcome; Triazoles; Tryptamines

2002
Real-world experiences in migraine therapy with rizatriptan.
    Headache, 2003, Volume: 43, Issue:3

    Topics: Acute Disease; Adult; Female; Follow-Up Studies; Humans; Male; Middle Aged; Migraine Disorders; Patient Satisfaction; Serotonin Receptor Agonists; Time Factors; Treatment Outcome; Triazoles; Tryptamines; United States

2003
Migraine treatment patterns and patient satisfaction with prior therapy: a substudy of a multicenter trial of rizatriptan effectiveness.
    Clinical therapeutics, 2003, Volume: 25, Issue:7

    Topics: Adolescent; Adult; Aged; Analgesics; Anti-Inflammatory Agents, Non-Steroidal; Ergot Alkaloids; Female; Humans; Male; Middle Aged; Migraine Disorders; Patient Satisfaction; Practice Patterns, Physicians'; Prospective Studies; Serotonin Receptor Agonists; Surveys and Questionnaires; Treatment Outcome; Triazoles; Tryptamines

2003
Rizatriptan RPD for severe migraine in the emergency department--a multicenter study.
    The Journal of emergency medicine, 2003, Volume: 25, Issue:3

    Topics: Adult; Emergency Medical Services; Female; Humans; Male; Middle Aged; Migraine Disorders; Treatment Outcome; Triazoles; Tryptamines

2003
Patient-reported benefits of rizatriptan compared with usual non-triptan therapy for migraine in a primary care setting.
    International journal of clinical practice, 2003, Volume: 57, Issue:9

    Topics: Adolescent; Adult; Aged; Analysis of Variance; Female; Humans; Male; Middle Aged; Migraine Disorders; Quality of Life; Serotonin Receptor Agonists; Triazoles; Tryptamines

2003
Comparison of rizatriptan 5 mg and 10 mg tablets and sumatriptan 25 mg and 50 mg tablets.
    Cephalalgia : an international journal of headache, 2004, Volume: 24, Issue:7

    Topics: Adult; Cross-Over Studies; Double-Blind Method; Female; Humans; Male; Migraine Disorders; Sumatriptan; Tablets; Triazoles; Tryptamines

2004
Rizatriptan versus rizatriptan plus rofecoxib versus rizatriptan plus tolfenamic acid in the acute treatment of migraine.
    BMC neurology, 2004, Jun-28, Volume: 4

    Topics: Acute Disease; Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase Inhibitors; Drug Therapy, Combination; Female; Humans; Lactones; Male; Middle Aged; Migraine Disorders; ortho-Aminobenzoates; Secondary Prevention; Serotonin Receptor Agonists; Sulfones; Treatment Outcome; Triazoles; Tryptamines

2004
Meta-analysis of oral triptans.
    Cephalalgia : an international journal of headache, 2004, Volume: 24, Issue:8

    Topics: Administration, Oral; Clinical Trials as Topic; Humans; Indoles; Meta-Analysis as Topic; Pain; Pyrrolidines; Serotonin Receptor Agonists; Triazoles; Tryptamines

2004
Rizatriptan 5 mg for the acute treatment of migraine in adolescents: results from a double-blind, single-attack study and two open-label, multiple-attack studies.
    Headache, 2004, Volume: 44, Issue:9

    Topics: Acute Disease; Adolescent; Double-Blind Method; Female; Humans; Male; Migraine Disorders; Recurrence; Serotonin Receptor Agonists; Time Factors; Treatment Outcome; Triazoles; Tryptamines

2004
Migraine treatment with rizatriptan and non-triptan usual care medications: a pharmacy-based study.
    Headache, 2004, Volume: 44, Issue:9

    Topics: Acute Disease; Adolescent; Adult; Analgesics; Female; Humans; Male; Middle Aged; Migraine Disorders; Patient Satisfaction; Pharmacies; Prospective Studies; Serotonin Receptor Agonists; Treatment Outcome; Triazoles; Tryptamines

2004
Pharmacokinetics of rizatriptan tablets during and between migraine attacks.
    Headache, 1999, Volume: 39, Issue:4

    Topics: Adolescent; Adult; Aged; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Migraine Disorders; Serotonin Receptor Agonists; Time Factors; Triazoles; Tryptamines

1999
Intranasal absorption of rizatriptan--in vivo pharmacokinetics and bioavailability study in humans.
    Die Pharmazie, 2005, Volume: 60, Issue:1

    Topics: Administration, Intranasal; Administration, Oral; Adult; Aerosols; Area Under Curve; Biological Availability; Blood Pressure; Chromatography, High Pressure Liquid; Cross-Over Studies; Heart Rate; Humans; Male; Nasal Mucosa; Serotonin Receptor Agonists; Spectrometry, Fluorescence; Tablets; Triazoles; Tryptamines

2005
Rizatriptan does not change cerebral blood flow velocity during migraine attacks.
    Brain research bulletin, 2005, Apr-30, Volume: 65, Issue:4

    Topics: Adult; Cerebral Cortex; Female; Functional Laterality; Humans; Laser-Doppler Flowmetry; Male; Middle Aged; Middle Cerebral Artery; Migraine Disorders; Regional Blood Flow; Serotonin Receptor Agonists; Time Factors; Triazoles; Tryptamines

2005
Multiple attack study on the available triptans in Italy versus placebo.
    European journal of neurology, 2005, Volume: 12, Issue:7

    Topics: Adult; Female; Humans; Indoles; Italy; Male; Middle Aged; Migraine Disorders; Oxazolidinones; Pyrrolidines; Serotonin Receptor Agonists; Sumatriptan; Treatment Outcome; Triazoles; Tryptamines

2005
Evaluation of the bioequivalence and pharmacokinetics of two formulations of rizatriptan after single oral administration in healthy volunteers.
    Arzneimittel-Forschung, 2005, Volume: 55, Issue:7

    Topics: Adult; Area Under Curve; Biological Availability; Blood Pressure; Capsules; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Double-Blind Method; Electrocardiography; Half-Life; Humans; Male; Serotonin Receptor Agonists; Tablets; Therapeutic Equivalency; Triazoles; Tryptamines

2005
Rizatriptan 10-mg wafer versus usual nontriptan therapy for migraine: analysis of return to function and patient preference.
    Headache, 2005, Volume: 45, Issue:9

    Topics: Adolescent; Adult; Aged; Female; Humans; Male; Middle Aged; Migraine Disorders; Patient Satisfaction; Prospective Studies; Recovery of Function; Serotonin Receptor Agonists; Triazoles; Tryptamines

2005
Prevention of motion sickness with rizatriptan: a double-blind, placebo-controlled pilot study.
    Medical science monitor : international medical journal of experimental and clinical research, 2006, Volume: 12, Issue:1

    Topics: Adult; Cross-Over Studies; Double-Blind Method; Female; Humans; Male; Middle Aged; Migraine Disorders; Motion Sickness; Placebos; Serotonin Receptor Agonists; Triazoles; Tryptamines

2006
Clinical efficacy of rizatriptan for patients with migraine: efficacy of drug therapy for migraine accompanied by tension headache-like symptoms, focusing on neck stiffness.
    The journal of headache and pain, 2005, Volume: 6, Issue:6

    Topics: Adult; Female; Humans; Male; Migraine Disorders; Muscular Diseases; Neck Muscles; Serotonin Receptor Agonists; Tension-Type Headache; Triazoles; Tryptamines

2005
Pharmacokinetic profile of rizatriptan 10-mg tablet and 10-mg orally disintegrating tablet administered with or without water in healthy subjects: an open-label, randomized, single-dose, 3-period crossover study.
    Journal of clinical pharmacology, 2006, Volume: 46, Issue:2

    Topics: Adolescent; Adult; Area Under Curve; Cross-Over Studies; Female; Humans; Male; Middle Aged; Serotonin Receptor Agonists; Tablets; Triazoles; Tryptamines; Water

2006
Preference for rizatriptan 10-mg wafer vs. eletriptan 40-mg tablet for acute treatment of migraine.
    Cephalalgia : an international journal of headache, 2006, Volume: 26, Issue:3

    Topics: Administration, Oral; Adolescent; Adult; Aged; Female; Humans; Male; Middle Aged; Migraine Disorders; Patient Satisfaction; Pyrrolidines; Serotonin Receptor Agonists; Tablets; Time Factors; Triazoles; Tryptamines

2006
Efficacy of Rizatriptan 10 mg administered early in a migraine attack.
    Headache, 2006, Volume: 46, Issue:6

    Topics: Acute Disease; Adult; Female; Humans; Male; Medical Records; Migraine Disorders; Patient Satisfaction; Serotonin Receptor Agonists; Severity of Illness Index; Time Factors; Triazoles; Tryptamines

2006
Rizatriptan vs. rizatriptan plus trimebutine for the acute treatment of migraine: a double-blind, randomized, cross-over, placebo-controlled study.
    Cephalalgia : an international journal of headache, 2006, Volume: 26, Issue:7

    Topics: Acute Disease; Adolescent; Adult; Aged; Drug Combinations; Female; Gastrointestinal Agents; Gastroparesis; Humans; Male; Middle Aged; Migraine Disorders; Nausea; Placebo Effect; Serotonin Receptor Agonists; Treatment Outcome; Triazoles; Trimebutine; Tryptamines

2006
Time to pain freedom and onset of pain relief with rizatriptan 10 mg and prescription usual-care oral medications in the acute treatment of migraine headaches: a multicenter, prospective, open-label, two-attack, crossover study.
    Clinical therapeutics, 2006, Volume: 28, Issue:6

    Topics: Adult; Cross-Over Studies; Female; Humans; Male; Migraine Disorders; Prospective Studies; Serotonin Receptor Agonists; Triazoles; Tryptamines

2006
A randomized trial of rizatriptan in migraine attacks in children.
    Neurology, 2006, Oct-10, Volume: 67, Issue:7

    Topics: Administration, Oral; Adolescent; Ambulatory Care; Child; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Female; Finland; Humans; Male; Migraine Disorders; Placebo Effect; Serotonin Receptor Agonists; Triazoles; Tryptamines

2006
Comparative sensitivity of stopwatch methodology and conventional pain assessment measures for detecting early response to triptans in migraine: results of a randomized, open-label pilot study.
    Clinical therapeutics, 2006, Volume: 28, Issue:8

    Topics: Adult; Analysis of Variance; Female; Humans; Male; Middle Aged; Migraine Disorders; Pain Measurement; Pilot Projects; Pyrrolidines; Serotonin Receptor Agonists; Triazoles; Tryptamines

2006
Patient preference in migraine therapy. A randomized, open-label, crossover clinical trial of acute treatment of migraine with oral almotriptan and rizatriptan.
    Journal of neurology, 2007, Volume: 254, Issue:2

    Topics: Administration, Oral; Adolescent; Adult; Aged; Cross-Over Studies; Female; Humans; Male; Meta-Analysis as Topic; Middle Aged; Migraine Disorders; Patient Satisfaction; Serotonin Receptor Agonists; Single-Blind Method; Time Factors; Triazoles; Tryptamines

2007
Rizatriptan for the acute treatment of ICHD-II proposed menstrual migraine: two prospective, randomized, placebo-controlled, double-blind studies.
    Cephalalgia : an international journal of headache, 2007, Volume: 27, Issue:5

    Topics: Acute Disease; Adolescent; Adult; Analgesics; Comorbidity; Double-Blind Method; Female; Humans; Menstruation Disturbances; Middle Aged; Migraine Disorders; Ohio; Pain Measurement; Placebo Effect; Serotonin Receptor Agonists; Treatment Outcome; Triazoles; Tryptamines

2007
Rizatriptan vs. ibuprofen in migraine: a randomised placebo-controlled trial.
    The journal of headache and pain, 2007, Volume: 8, Issue:3

    Topics: Acute Disease; Adult; Anti-Inflammatory Agents, Non-Steroidal; Female; Humans; Ibuprofen; Male; Migraine Disorders; Sample Size; Serotonin Receptor Agonists; Treatment Outcome; Triazoles; Tryptamines

2007
Symptoms of cutaneous sensitivity pre-treatment and post-treatment: results from the rizatriptan TAME studies.
    Cephalalgia : an international journal of headache, 2007, Volume: 27, Issue:9

    Topics: Adult; Comorbidity; Double-Blind Method; Female; Headache; Humans; Hyperalgesia; Male; Migraine Disorders; Placebo Effect; Prevalence; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Serotonin Receptor Agonists; Touch; Treatment Outcome; Triazoles; Tryptamines; United States

2007
Traditional acupuncture in migraine: a controlled, randomized study.
    Headache, 2008, Volume: 48, Issue:3

    Topics: Acupuncture Therapy; Adult; Female; Humans; Male; Medicine, Chinese Traditional; Middle Aged; Migraine Disorders; Placebos; Serotonin Receptor Agonists; Single-Blind Method; Triazoles; Tryptamines

2008
Influence of an e-mail with a drug information attachment on sales of prescribed drugs: a randomized controlled study.
    BMC clinical pharmacology, 2007, Oct-18, Volume: 7

    Topics: Cost-Benefit Analysis; Drug Information Services; Drug Prescriptions; Electronic Mail; Humans; Information Dissemination; Patient Selection; Practice Patterns, Physicians'; Serotonin Receptor Agonists; Sweden; Time Factors; Triazoles; Tryptamines

2007
Efficacy of rizatriptan for menstrual migraine in an early intervention model: a prospective subgroup analysis of the rizatriptan TAME (Treat A Migraine Early) studies.
    Headache, 2008, Volume: 48, Issue:2

    Topics: Adult; Disability Evaluation; Double-Blind Method; Drug Evaluation; Female; Humans; Menstruation Disturbances; Migraine Disorders; Pain Measurement; Prospective Studies; Retrospective Studies; Serotonin Receptor Agonists; Time Factors; Triazoles; Tryptamines

2008
Elimination of migraine-associated nausea in patients treated with rizatriptan orally disintegrating tablet (ODT): a randomized, double-blind, placebo-controlled study.
    Headache, 2008, Volume: 48, Issue:3

    Topics: Administration, Oral; Adult; Double-Blind Method; Female; Humans; Male; Migraine Disorders; Nausea; Placebos; Serotonin Receptor Agonists; Triazoles; Tryptamines

2008
Rizatriptan efficacy in ICHD-II pure menstrual migraine and menstrually related migraine.
    Headache, 2008, Volume: 48, Issue:8

    Topics: Adolescent; Adult; Clinical Protocols; Disability Evaluation; Double-Blind Method; Female; Humans; Menstruation Disturbances; Migraine Disorders; Pain Measurement; Prospective Studies; Retrospective Studies; Serotonin Receptor Agonists; Treatment Outcome; Triazoles; Tryptamines; Young Adult

2008
Effects of rizatriptan on the contingent negative variation in healthy women.
    Cephalalgia : an international journal of headache, 2008, Volume: 28, Issue:9

    Topics: Adult; Arousal; Contingent Negative Variation; Double-Blind Method; Electroencephalography; Female; Habituation, Psychophysiologic; Humans; Models, Neurological; Reference Values; Serotonin; Serotonin Receptor Agonists; Triazoles; Tryptamines

2008
Efficacy and tolerability of coadministration of rizatriptan and acetaminophen vs rizatriptan or acetaminophen alone for acute migraine treatment.
    Headache, 2008, Volume: 48, Issue:6

    Topics: Acetaminophen; Acute Disease; Adult; Aged; Analgesics, Non-Narcotic; Double-Blind Method; Drug Therapy, Combination; Drug Tolerance; Female; Humans; Male; Middle Aged; Migraine Disorders; Serotonin Receptor Agonists; Treatment Outcome; Triazoles; Tryptamines; United States

2008
A randomized double-blind study comparing rizatriptan, dexamethasone, and the combination of both in the acute treatment of menstrually related migraine.
    Headache, 2008, Volume: 48, Issue:9

    Topics: Cross-Over Studies; Dexamethasone; Drug Therapy, Combination; Female; Headache; Humans; Menstruation; Triazoles; Tryptamines

2008
Impact of recent prior opioid use on rizatriptan efficacy. A post hoc pooled analysis.
    Headache, 2009, Volume: 49, Issue:3

    Topics: Adult; Dose-Response Relationship, Drug; Female; Humans; Male; Migraine Disorders; Opioid-Related Disorders; Pain Measurement; Serotonin Receptor Agonists; Time Factors; Triazoles; Tryptamines

2009
Migraine treatment with rizatriptan and almotriptan: a crossover study.
    Headache, 2009, Volume: 49, Issue:5

    Topics: Adult; Cross-Over Studies; Female; Humans; Male; Middle Aged; Migraine Disorders; Pain Measurement; Patient Satisfaction; Proportional Hazards Models; Prospective Studies; Serotonin Receptor Agonists; Time Factors; Treatment Outcome; Triazoles; Tryptamines

2009
Rizatriptan 10-mg ODT for early treatment of migraine and impact of migraine education on treatment response.
    Headache, 2009, Volume: 49, Issue:5

    Topics: Administration, Oral; Adult; Double-Blind Method; Drug Administration Schedule; Early Diagnosis; Female; Humans; Male; Middle Aged; Migraine Disorders; Pain Measurement; Patient Education as Topic; Placebo Effect; Self-Assessment; Serotonin Receptor Agonists; Time Factors; Treatment Outcome; Triazoles; Tryptamines

2009
A pilot study of rizatriptan and visually-induced motion sickness in migraineurs.
    International journal of medical sciences, 2009, Aug-06, Volume: 6, Issue:4

    Topics: Adult; Double-Blind Method; Female; Humans; Migraine Disorders; Motion Sickness; Serotonin Receptor Agonists; Treatment Outcome; Triazoles; Tryptamines

2009
Elevated saliva calcitonin gene-related peptide levels during acute migraine predict therapeutic response to rizatriptan.
    Headache, 2009, Volume: 49, Issue:9

    Topics: Acute Disease; Adult; Biomarkers; Calcitonin Gene-Related Peptide; Drug Resistance; Female; Humans; Male; Middle Aged; Migraine Disorders; Predictive Value of Tests; Saliva; Salivary Glands; Sensitivity and Specificity; Serotonin Receptor Agonists; Triazoles; Tryptamines; Up-Regulation; Young Adult

2009
A comparison of migraine patients with and without allodynic symptoms.
    The Clinical journal of pain, 2009, Volume: 25, Issue:8

    Topics: Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Asian People; Double-Blind Method; Female; Humans; Ibuprofen; Male; Middle Aged; Migraine Disorders; Pain; Pain Measurement; Serotonin Receptor Agonists; Triazoles; Tryptamines; Young Adult

2009
A double-blind, randomized, multicenter, Italian study of frovatriptan versus rizatriptan for the acute treatment of migraine.
    The journal of headache and pain, 2011, Volume: 12, Issue:2

    Topics: Adolescent; Adult; Aged; Carbazoles; Double-Blind Method; Drug Administration Schedule; Female; Humans; Italy; Male; Middle Aged; Migraine Disorders; Serotonin Receptor Agonists; Triazoles; Tryptamines; Young Adult

2011
Rizatriptan reduces vestibular-induced motion sickness in migraineurs.
    The journal of headache and pain, 2011, Volume: 12, Issue:1

    Topics: Adult; Double-Blind Method; Female; Humans; Male; Middle Aged; Migraine Disorders; Motion Sickness; Serotonin Receptor Agonists; Treatment Outcome; Triazoles; Tryptamines; Vestibular Diseases; Young Adult

2011
Long-term tolerability of telcagepant for acute treatment of migraine in a randomized trial.
    Headache, 2011, Volume: 51, Issue:1

    Topics: Adult; Aged; Azepines; Calcitonin Gene-Related Peptide Receptor Antagonists; Double-Blind Method; Endpoint Determination; Female; Humans; Imidazoles; Male; Middle Aged; Migraine Disorders; Triazoles; Tryptamines

2011
Efficacy and tolerability of rizatriptan for the treatment of acute migraine in sumatriptan non-responders.
    Cephalalgia : an international journal of headache, 2011, Volume: 31, Issue:7

    Topics: Adult; Aged; Cross-Over Studies; Double-Blind Method; Female; Humans; Male; Middle Aged; Migraine Disorders; Serotonin Receptor Agonists; Sumatriptan; Treatment Outcome; Triazoles; Tryptamines; Young Adult

2011
Efficacy of frovatriptan in the acute treatment of menstrually related migraine: analysis of a double-blind, randomized, cross-over, multicenter, Italian, comparative study versus rizatriptan.
    The journal of headache and pain, 2011, Volume: 12, Issue:6

    Topics: Acute Disease; Adolescent; Adult; Aged; Carbazoles; Cross-Over Studies; Double-Blind Method; Female; Humans; Italy; Menstruation Disturbances; Middle Aged; Migraine Disorders; Serotonin Receptor Agonists; Triazoles; Tryptamines; Young Adult

2011
Rizatriptan for treatment of acute migraine in patients taking topiramate for migraine prophylaxis.
    Headache, 2012, Volume: 52, Issue:1

    Topics: Acute Disease; Adolescent; Adult; Aged; Disability Evaluation; Double-Blind Method; Female; Fructose; Humans; Male; Middle Aged; Migraine Disorders; Neuroprotective Agents; Pain Measurement; Prospective Studies; Serotonin Receptor Agonists; Severity of Illness Index; Time Factors; Topiramate; Treatment Outcome; Triazoles; Tryptamines; Young Adult

2012
Pharmacokinetics and tolerability of rizatriptan in pediatric migraineurs in a randomized study.
    Headache, 2012, Volume: 52, Issue:4

    Topics: Adolescent; Child; Double-Blind Method; Female; Headache; Humans; Male; Migraine Disorders; Triazoles; Tryptamines

2012
Rizatriptan in migraineurs with unilateral cranial autonomic symptoms: a double-blind trial.
    The journal of headache and pain, 2012, Volume: 13, Issue:5

    Topics: Adult; Autonomic Nervous System Diseases; Chi-Square Distribution; Double-Blind Method; Female; Functional Laterality; Humans; Male; Middle Aged; Migraine Disorders; Pain Measurement; Physical Examination; Serotonin Receptor Agonists; Time Factors; Treatment Outcome; Triazoles; Tryptamines

2012
Efficacy and tolerability of rizatriptan in pediatric migraineurs: results from a randomized, double-blind, placebo-controlled trial using a novel adaptive enrichment design.
    Cephalalgia : an international journal of headache, 2012, Volume: 32, Issue:10

    Topics: Adolescent; Child; Double-Blind Method; Female; Humans; Male; Migraine Disorders; Serotonin Receptor Agonists; Treatment Outcome; Triazoles; Tryptamines

2012
Long-term open-label safety study of rizatriptan acute treatment in pediatric migraineurs.
    Headache, 2013, Volume: 53, Issue:1

    Topics: Adolescent; Child; Female; Humans; Male; Migraine Disorders; Serotonin Receptor Agonists; Triazoles; Tryptamines

2013
Acupuncture versus valproic acid in the prophylaxis of migraine without aura: a prospective controlled study.
    Minerva anestesiologica, 2013, Volume: 79, Issue:6

    Topics: Acupuncture Therapy; Adult; Anticonvulsants; Female; Humans; Male; Migraine without Aura; Pain Measurement; Prospective Studies; Sample Size; Serotonin Agents; Triazoles; Tryptamines; Valproic Acid

2013
Frovatriptan and rizatriptan economic EVAluation: the FREEVA study.
    The journal of headache and pain, 2013, Dec-11, Volume: 14

    Topics: Adult; Analgesics; Carbazoles; Cost-Benefit Analysis; Cross-Over Studies; Double-Blind Method; Female; Humans; Male; Migraine Disorders; Triazoles; Tryptamines

2013
Altered placebo and drug labeling changes the outcome of episodic migraine attacks.
    Science translational medicine, 2014, Jan-08, Volume: 6, Issue:218

    Topics: Drug Labeling; Endpoint Determination; Humans; Migraine Disorders; Pain Measurement; Placebos; Treatment Outcome; Triazoles; Tryptamines

2014
Efficacy and pharmacokinetic activity of frovatriptan compared to rizatriptan in patients with moderate-to-severe migraine.
    Drug design, development and therapy, 2014, Volume: 8

    Topics: Adult; Carbazoles; Cross-Over Studies; Double-Blind Method; Female; Half-Life; Humans; Male; Middle Aged; Migraine Disorders; Pilot Projects; Recurrence; Serotonin Receptor Agonists; Severity of Illness Index; Time Factors; Treatment Outcome; Triazoles; Tryptamines

2014
Theory-based analysis of clinical efficacy of triptans using receptor occupancy.
    The journal of headache and pain, 2014, Dec-08, Volume: 15

    Topics: Humans; Migraine Disorders; Oxazolidinones; Piperidines; Pyrrolidines; Serotonin 5-HT1 Receptor Agonists; Sumatriptan; Treatment Outcome; Triazoles; Tryptamines

2014
Clinicopharmacological comparative study of rizatriptan versus conventional therapy in migraine.
    Journal of the Indian Medical Association, 2014, Volume: 112, Issue:1

    Topics: Acetaminophen; Adolescent; Adult; Aged; Alprazolam; Analgesics, Non-Narcotic; Female; Flunarizine; Humans; Male; Metoclopramide; Middle Aged; Migraine Disorders; Prospective Studies; Serotonin Receptor Agonists; Treatment Outcome; Triazoles; Tryptamines; Vasodilator Agents; Young Adult

2014
[Comparison of triptans, NSAID and combination in migraine attack treatment].
    Agri : Agri (Algoloji) Dernegi'nin Yayin organidir = The journal of the Turkish Society of Algology, 2016, Volume: 28, Issue:3

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Drug Therapy, Combination; Female; Humans; Male; Migraine Disorders; Pain Measurement; Piroxicam; Serotonin Antagonists; Treatment Outcome; Triazoles; Tryptamines

2016
[Clinical observation on horizontal penetration needling combined with rizatriptan monobenzoate tablets for migraine without aura in acute stage].
    Zhongguo zhen jiu = Chinese acupuncture & moxibustion, 2021, Sep-12, Volume: 41, Issue:9

    Topics: Acupuncture Points; Acupuncture Therapy; Humans; Migraine without Aura; Tablets; Treatment Outcome; Triazoles; Tryptamines

2021
[Comparative clinical study of pharmacokinetics and bioequivalence of Relonova and Maxalt].
    Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2023, Volume: 123, Issue:8

    Topics: Adult; Body Weight; Female; Humans; Male; Therapeutic Equivalency; Triazoles; Tryptamines; Young Adult

2023

Other Studies

142 other study(ies) available for triazoles and rizatriptan

ArticleYear
Synthesis and serotonergic activity of N,N-dimethyl-2-[5-(1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]ethylamine and analogues: potent agonists for 5-HT1D receptors.
    Journal of medicinal chemistry, 1995, May-12, Volume: 38, Issue:10

    Topics: Animals; Rabbits; Rats; Serotonin Receptor Agonists; Structure-Activity Relationship; Triazoles; Tryptamines

1995
A comparison of the contractile effects of 5-hydroxytryptamine, sumatriptan and MK-462 on human coronary artery in vitro.
    British journal of clinical pharmacology, 1995, Volume: 40, Issue:3

    Topics: Coronary Vessels; Dose-Response Relationship, Drug; Humans; In Vitro Techniques; Muscle Contraction; Muscle, Smooth, Vascular; Serotonin; Serotonin Receptor Agonists; Sumatriptan; Time Factors; Triazoles; Tryptamines; Vasoconstriction

1995
The use of stable isotope labeling and liquid chromatography/tandem mass spectrometry techniques to study the pharmacokinetics and bioavailability of the antimigraine drug, MK-0462 (rizatriptan) in dogs.
    Rapid communications in mass spectrometry : RCM, 1996, Volume: 10, Issue:9

    Topics: Administration, Oral; Animals; Biological Availability; Calibration; Chromatography, High Pressure Liquid; Chromatography, Liquid; Dogs; Injections, Intravenous; Male; Mass Spectrometry; Serotonin Receptor Agonists; Triazoles; Tryptamines

1996
Quantitation of the 5HT1D agonists MK-462 and sumatriptan in plasma by liquid chromatography-atmospheric pressure chemical ionization mass spectrometry.
    Journal of chromatography. A, 1996, Mar-01, Volume: 726, Issue:1-2

    Topics: Chromatography, High Pressure Liquid; Humans; Mass Spectrometry; Pressure; Reference Values; Reproducibility of Results; Serotonin Receptor Agonists; Sumatriptan; Triazoles; Tryptamines

1996
5-HT1D receptor agonists and human coronary artery reactivity in vitro: crossover comparisons of 5-HT and sumatriptan with rizatriptan and L-741,519.
    British journal of clinical pharmacology, 1996, Volume: 42, Issue:4

    Topics: Adult; Aged; Arteries; Coronary Vessels; Female; Humans; In Vitro Techniques; Male; Middle Aged; Muscle Contraction; Receptor, Serotonin, 5-HT1D; Receptors, Serotonin; Serotonin; Serotonin Receptor Agonists; Sumatriptan; Triazoles; Tryptamines

1996
Development and validation of a general non-digestive method for the determination of palladium in bulk pharmaceutical chemicals and their synthetic intermediates by graphite furnace atomic absorption spectroscopy.
    Journal of pharmaceutical and biomedical analysis, 1997, Volume: 15, Issue:5

    Topics: Acetates; Anticonvulsants; Chemistry, Pharmaceutical; Cyclohexylamines; Cyclopropanes; Enzyme Inhibitors; Graphite; Indoles; Linear Models; Nitric Acid; Palladium; Quinolines; Reproducibility of Results; Sensitivity and Specificity; Serotonin Receptor Agonists; Solvents; Spectrophotometry, Atomic; Sulfides; Triazoles; Tryptamines

1997
Rizatriptan has central antinociceptive effects against durally evoked responses.
    European journal of pharmacology, 1997, Jun-05, Volume: 328, Issue:1

    Topics: Action Potentials; Analysis of Variance; Animals; Blood-Brain Barrier; Disease Models, Animal; Dose-Response Relationship, Drug; Dura Mater; Electric Stimulation; Electrophysiology; Injections, Intravenous; Male; Microelectrodes; Migraine Disorders; Neurons; Pain; Rats; Rats, Sprague-Dawley; Serotonin Receptor Agonists; Triazoles; Trigeminal Caudal Nucleus; Tryptamines

1997
The novel anti-migraine agent rizatriptan inhibits neurogenic dural vasodilation and extravasation.
    European journal of pharmacology, 1997, Jun-05, Volume: 328, Issue:1

    Topics: Analysis of Variance; Animals; Blood Proteins; Calcitonin Gene-Related Peptide; Disease Models, Animal; Dura Mater; Electric Stimulation; Injections, Intravenous; Lethal Dose 50; Male; Meningeal Arteries; Migraine Disorders; Neuromuscular Junction; Rats; Rats, Sprague-Dawley; Serotonin Receptor Agonists; Substance P; Triazoles; Trigeminal Nuclei; Tryptamines; Vasodilation

1997
Pharmacological analysis of the haemodynamic effects of 5-HT1B/D receptor agonists in the normotensive rat.
    British journal of pharmacology, 1998, Volume: 123, Issue:2

    Topics: Animals; Autonomic Nervous System; Blood Pressure; Drug Interactions; Heart Rate; Hemodynamics; Male; Oxazoles; Oxazolidinones; Parasympathetic Nervous System; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1B; Receptors, Serotonin; Serotonin Receptor Agonists; Sumatriptan; Triazoles; Tryptamines

1998
Please don't hi-jack "quality of life".
    Cephalalgia : an international journal of headache, 1998, Volume: 18, Issue:4

    Topics: Humans; Migraine Disorders; Quality of Life; Serotonin Receptor Agonists; Triazoles; Tryptamines

1998
Coronary side-effect potential of current and prospective antimigraine drugs.
    Circulation, 1998, Jul-07, Volume: 98, Issue:1

    Topics: Adolescent; Adult; Aged; Angina Pectoris; Child; Coronary Vessels; Dihydroergotamine; Ergotamine; Female; Humans; In Vitro Techniques; Indoles; Male; Methysergide; Middle Aged; Migraine Disorders; Piperidines; Sulfonamides; Sumatriptan; Triazoles; Tryptamines; Vasoconstrictor Agents

1998
Oral migraine drug approved for marketing.
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 1998, Aug-15, Volume: 55, Issue:16

    Topics: Administration, Oral; Humans; Migraine Disorders; Serotonin Receptor Agonists; Triazoles; Tryptamines

1998
New "triptans" and other drugs for migraine.
    The Medical letter on drugs and therapeutics, 1998, Oct-09, Volume: 40, Issue:1037

    Topics: Adrenergic beta-Antagonists; Amitriptyline; Anti-Inflammatory Agents, Non-Steroidal; Antidepressive Agents, Tricyclic; Calcium Channel Blockers; Dihydroergotamine; Drug Interactions; Ergotamine; Humans; Indoles; Methysergide; Migraine Disorders; Naproxen; Oxazoles; Oxazolidinones; Piperidines; Propranolol; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists; Sumatriptan; Time Factors; Timolol; Triazoles; Tryptamines; Valproic Acid; Vasoconstrictor Agents

1998
Comparison of the vasoconstrictor effects of rizatriptan and sumatriptan in human isolated cranial arteries: immunohistological demonstration of the involvement of 5-HT1B-receptors.
    British journal of clinical pharmacology, 1998, Volume: 46, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Coronary Vessels; Female; Humans; Immunohistochemistry; In Vitro Techniques; Male; Meningeal Arteries; Middle Aged; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Receptors, Serotonin; Sumatriptan; Triazoles; Tryptamines; Vasoconstrictor Agents

1998
Characterisation of the 5-HT receptor binding profile of eletriptan and kinetics of [3H]eletriptan binding at human 5-HT1B and 5-HT1D receptors.
    European journal of pharmacology, 1999, Mar-05, Volume: 368, Issue:2-3

    Topics: Animals; Binding, Competitive; Cell Line; Cold Temperature; COS Cells; HeLa Cells; Humans; Indoles; Kinetics; Oxazoles; Oxazolidinones; Piperidines; Pyrrolidines; Radioligand Assay; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Receptors, Serotonin; Sumatriptan; Triazoles; Tritium; Tryptamines

1999
New drugs 99, Part IV.
    Nursing, 1999, Volume: 29, Issue:7

    Topics: Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Antidepressive Agents, Second-Generation; Antihypertensive Agents; Benzimidazoles; Benzoates; Biphenyl Compounds; Cefdinir; Cephalosporins; Citalopram; Drug Therapy; Etanercept; Humans; Immunoglobulin G; Isoxazoles; Leflunomide; Receptors, Tumor Necrosis Factor; Serotonin Receptor Agonists; Telmisartan; Tetrazoles; Triazoles; Tryptamines; United States; United States Food and Drug Administration

1999
Disposition and pharmacokinetics of the antimigraine drug, rizatriptan, in humans.
    Drug metabolism and disposition: the biological fate of chemicals, 2000, Volume: 28, Issue:1

    Topics: Administration, Oral; Area Under Curve; Carbon Radioisotopes; Chromatography, High Pressure Liquid; Cross-Over Studies; Feces; Humans; Infusions, Intravenous; Male; Migraine Disorders; Reference Values; Serotonin Receptor Agonists; Tissue Distribution; Triazoles; Tryptamines

2000
Determination of antimigraine compounds rizatriptan, zolmitriptan, naratriptan and sumatriptan in human serum by liquid chromatography/electrospray tandem mass spectrometry.
    Rapid communications in mass spectrometry : RCM, 2000, Volume: 14, Issue:3

    Topics: Bufotenin; Chromatography, High Pressure Liquid; Humans; Indoles; Mass Spectrometry; Migraine Disorders; Molecular Structure; Oxazoles; Oxazolidinones; Piperidines; Sensitivity and Specificity; Serotonin Receptor Agonists; Sumatriptan; Triazoles; Tryptamines; Vasoconstrictor Agents

2000
Rizatriptan tablet versus wafer: patient preference.
    Headache, 2000, Volume: 40, Issue:5

    Topics: Adult; Dosage Forms; Drug Evaluation; Freeze Drying; Humans; Migraine Disorders; Patient Satisfaction; Retrospective Studies; Serotonin Receptor Agonists; Tablets; Triazoles; Tryptamines

2000
Rizatriptan in the treatment of menstrual migraine.
    Obstetrics and gynecology, 2000, Volume: 96, Issue:2

    Topics: Administration, Oral; Adult; Cross-Over Studies; Double-Blind Method; Female; Humans; Male; Menstruation Disturbances; Migraine Disorders; Multicenter Studies as Topic; Odds Ratio; Randomized Controlled Trials as Topic; Retrospective Studies; Serotonin Receptor Agonists; Treatment Outcome; Triazoles; Tryptamines; United States

2000
Triptans to the rescue: effective therapy for migraine headaches in the workplace.
    Mayo Clinic proceedings, 2000, Volume: 75, Issue:8

    Topics: Absenteeism; Adult; Cost-Benefit Analysis; Efficiency; Female; Humans; Indoles; Injections, Subcutaneous; Male; Migraine Disorders; Oxazoles; Oxazolidinones; Piperidines; Randomized Controlled Trials as Topic; Self Administration; Serotonin Receptor Agonists; Sumatriptan; Treatment Outcome; Triazoles; Tryptamines; Workplace

2000
A comment on time-to-event analysis for headache relief.
    Cephalalgia : an international journal of headache, 2000, Volume: 20, Issue:4

    Topics: Analgesics; Headache; Humans; Indoles; Oxazolidinones; Piperidines; Randomized Controlled Trials as Topic; Serotonin Receptor Agonists; Sumatriptan; Time Factors; Triazoles; Tryptamines

2000
Treatment options for acute migraine.
    RN, 2000, Volume: 63, Issue:10

    Topics: Acute Disease; Adult; Female; Humans; Migraine Disorders; Oxazolidinones; Patient Selection; Practice Guidelines as Topic; Serotonin Receptor Agonists; Sumatriptan; Triazoles; Tryptamines; Vasoconstrictor Agents

2000
Determinants of patient satisfaction with migraine therapy.
    Cephalalgia : an international journal of headache, 2000, Volume: 20, Issue:6

    Topics: Adult; Analgesics; Female; Humans; Male; Middle Aged; Migraine Disorders; Nausea; Patient Satisfaction; Photophobia; Placebos; Randomized Controlled Trials as Topic; Severity of Illness Index; Single-Blind Method; Time Factors; Triazoles; Tryptamines; Vomiting; White People

2000
Rizatriptan: a new milestone in migraine treatment. Introduction.
    Cephalalgia : an international journal of headache, 2000, Volume: 20 Suppl 1

    Topics: Humans; Migraine Disorders; Serotonin Receptor Agonists; Treatment Outcome; Triazoles; Tryptamines

2000
Rizatriptan: a new milestone in migraine treatment. Closing remarks.
    Cephalalgia : an international journal of headache, 2000, Volume: 20 Suppl 1

    Topics: Clinical Trials as Topic; Humans; Migraine Disorders; Serotonin Receptor Agonists; Triazoles; Tryptamines

2000
Newer triptans: emphasis on rizatriptan.
    Neurology, 2000, Volume: 55, Issue:9 Suppl 2

    Topics: Humans; Migraine Disorders; Serotonin Receptor Agonists; Triazoles; Tryptamines

2000
Oral therapy for migraine: comparisons between rizatriptan and sumatriptan. A review of four randomized, double-blind clinical trials.
    Neurology, 2000, Volume: 55, Issue:9 Suppl 2

    Topics: Administration, Oral; Dose-Response Relationship, Drug; Double-Blind Method; Humans; Migraine Disorders; Randomized Controlled Trials as Topic; Serotonin Receptor Agonists; Sumatriptan; Time Factors; Triazoles; Tryptamines

2000
Rizatriptan versus usual care in long-term treatment of migraine.
    Neurology, 2000, Volume: 55, Issue:9 Suppl 2

    Topics: Humans; Migraine Disorders; Serotonin Receptor Agonists; Sumatriptan; Time Factors; Triazoles; Tryptamines

2000
[Migraine therapy. Help for the head--without risk for to the heart].
    MMW Fortschritte der Medizin, 2000, Jan-13, Volume: 142, Issue:1-2

    Topics: Hemodynamics; Humans; Migraine Disorders; Serotonin Receptor Agonists; Treatment Outcome; Triazoles; Tryptamines

2000
Rizatriptan wafer--sublingual vs. placebo at the onset of acute migraine.
    Cephalalgia : an international journal of headache, 2001, Volume: 21, Issue:1

    Topics: Administration, Sublingual; Humans; Migraine Disorders; Serotonin Receptor Agonists; Time Factors; Triazoles; Tryptamines

2001
Effect of rizatriptan in the spectrum of headache.
    Headache, 2001, Volume: 41, Issue:6

    Topics: Clinical Trials as Topic; Humans; Migraine Disorders; Retrospective Studies; Serotonin Receptor Agonists; Sumatriptan; Tension-Type Headache; Triazoles; Tryptamines

2001
Migraine treatment outcomes with rizatriptan in triptan-naive patients: a naturalistic study.
    Clinical therapeutics, 2001, Volume: 23, Issue:6

    Topics: Activities of Daily Living; Adult; Female; Humans; Male; Migraine Disorders; Patient Satisfaction; Serotonin Receptor Agonists; Surveys and Questionnaires; Tablets; Treatment Outcome; Triazoles; Tryptamines

2001
The anti-migraine 5-HT(1B/1D) agonist rizatriptan inhibits neurogenic dural vasodilation in anaesthetized guinea-pigs.
    British journal of pharmacology, 2001, Volume: 133, Issue:7

    Topics: Anesthesia; Animals; Benzamides; Calcitonin Gene-Related Peptide; Chromans; Dose-Response Relationship, Drug; Dura Mater; Guinea Pigs; Humans; Indoles; Male; Meningeal Arteries; Migraine Disorders; Peptide Fragments; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Receptors, Serotonin; Serotonin Receptor Agonists; Triazoles; Tryptamines; Vasodilation

2001
Effect of rizatriptan and other triptans on the nausea symptom of migraine: a post hoc analysis.
    Headache, 2001, Volume: 41, Issue:8

    Topics: Administration, Oral; Adult; Double-Blind Method; Humans; Indoles; Migraine Disorders; Nausea; Oxazolidinones; Piperidines; Randomized Controlled Trials as Topic; Serotonin Receptor Agonists; Sumatriptan; Triazoles; Tryptamines; Vasoconstrictor Agents

2001
Migraine MLT-down: an unusual presentation of migraine in patients with aspartame-triggered headaches.
    Headache, 2001, Volume: 41, Issue:9

    Topics: Adolescent; Adult; Aspartame; Female; Humans; Male; Migraine Disorders; Serotonin Receptor Agonists; Sweetening Agents; Triazoles; Tryptamines

2001
[Therapy of an acute migraine attack. Uniform patient vote for rizatriptan].
    MMW Fortschritte der Medizin, 2001, Nov-22, Volume: 143, Issue:47

    Topics: Germany; Humans; Migraine Disorders; Patient Satisfaction; Serotonin Receptor Agonists; Treatment Outcome; Triazoles; Tryptamines

2001
Cluster headache without autonomic symptoms?
    Cephalalgia : an international journal of headache, 2001, Volume: 21, Issue:9

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Inflammatory Agents; Anti-Ulcer Agents; Benzimidazoles; Cluster Headache; Diagnosis, Differential; Glucocorticoids; Humans; Male; Omeprazole; Pantoprazole; Prednisolone; Serotonin Receptor Agonists; Sulfoxides; Triazoles; Tryptamines

2001
Evidence-based migraine therapy.
    Cephalalgia : an international journal of headache, 2001, Volume: 21, Issue:9

    Topics: Evidence-Based Medicine; Humans; Migraine Disorders; Serotonin Receptor Agonists; Sumatriptan; Triazoles; Tryptamines

2001
Treatment of migraine with rizatriptan: when to take the medication.
    Headache, 2002, Volume: 42, Issue:1

    Topics: Drug Administration Schedule; Humans; Migraine Disorders; Prospective Studies; Serotonin Receptor Agonists; Severity of Illness Index; Triazoles; Tryptamines

2002
Comparison of triptan tablet consumption per attack: a prospective study of migraineurs in Spain.
    Headache, 2002, Volume: 42, Issue:2

    Topics: Female; Humans; Indoles; Male; Migraine Disorders; Oxazolidinones; Piperidines; Prospective Studies; Serotonin Receptor Agonists; Sumatriptan; Tablets; Triazoles; Tryptamines

2002
[New meta-analysis of triptanes. Concrete help, so the choice doesn't become overwhelming].
    MMW Fortschritte der Medizin, 2002, May-06, Volume: Suppl 2

    Topics: Humans; Meta-Analysis as Topic; Migraine Disorders; Patient Satisfaction; Serotonin Receptor Agonists; Treatment Outcome; Triazoles; Tryptamines

2002
[Good ruler for assessing effectiveness. Pain free with only one tablet].
    MMW Fortschritte der Medizin, 2002, May-06, Volume: Suppl 2

    Topics: Dose-Response Relationship, Drug; Humans; Migraine Disorders; Serotonin Receptor Agonists; Treatment Outcome; Triazoles; Tryptamines

2002
[Controlling migraine with highly effective triptanes. Lowers rate of drug use].
    MMW Fortschritte der Medizin, 2002, May-06, Volume: Suppl 2

    Topics: Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Migraine Disorders; Serotonin Receptor Agonists; Treatment Outcome; Triazoles; Tryptamines

2002
Comparison of rizatriptan and other triptans on stringent measures of efficacy.
    Neurology, 2002, Sep-10, Volume: 59, Issue:5

    Topics: Humans; Migraine Disorders; Serotonin Receptor Agonists; Triazoles; Tryptamines

2002
Comparison of rizatriptan and other triptans on stringent measures of efficacy.
    Neurology, 2002, Sep-10, Volume: 59, Issue:5

    Topics: Humans; Migraine Disorders; Serotonin Receptor Agonists; Triazoles; Tryptamines

2002
Restoring migraine sufferers' ability to function normally: a comparison of rizatriptan and other triptans in randomized trials.
    European neurology, 2002, Volume: 48, Issue:3

    Topics: Administration, Oral; Adolescent; Adult; Aged; Female; Humans; Indoles; Male; Middle Aged; Migraine Disorders; Oxazolidinones; Piperidines; Randomized Controlled Trials as Topic; Retrospective Studies; Serotonin Receptor Agonists; Sumatriptan; Treatment Outcome; Triazoles; Tryptamines

2002
Sum of Pain Intensity Differences (SPID) in migraine trials. A comment based on four rizatriptan trials.
    Cephalalgia : an international journal of headache, 2002, Volume: 22, Issue:8

    Topics: Humans; Migraine Disorders; Outcome Assessment, Health Care; Pain Measurement; Serotonin Receptor Agonists; Triazoles; Tryptamines

2002
Further evaluation of rizatriptan in menstrual migraine: retrospective analysis of long-term data.
    Headache, 2002, Volume: 42, Issue:9

    Topics: Administration, Oral; Adult; Female; Humans; Menstruation; Migraine Disorders; Retrospective Studies; Serotonin Receptor Agonists; Triazoles; Tryptamines

2002
Rizatriptan 5mg is not efficacious for migraine in adolescents.
    Headache, 2002, Volume: 42, Issue:8

    Topics: Acute Disease; Adolescent; Humans; Migraine Disorders; Randomized Controlled Trials as Topic; Serotonin Receptor Agonists; Triazoles; Tryptamines

2002
[New onset headache. Which patients should be sent for CT imaging?].
    MMW Fortschritte der Medizin, 2002, Oct-24, Volume: 144, Issue:43

    Topics: Acute Disease; Brain Diseases; Diagnosis, Differential; Drug Administration Schedule; Headache; Humans; Migraine Disorders; Tomography, X-Ray Computed; Triazoles; Tryptamines

2002
[New therapeutic recommendations for severe migraine. High beginning dosage rather than slow dosage increase].
    MMW Fortschritte der Medizin, 2003, Jan-30, Volume: 145, Issue:5

    Topics: Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Migraine Disorders; Serotonin Receptor Agonists; Treatment Outcome; Triazoles; Tryptamines

2003
Eletriptan metabolism by human hepatic CYP450 enzymes and transport by human P-glycoprotein.
    Drug metabolism and disposition: the biological fate of chemicals, 2003, Volume: 31, Issue:7

    Topics: Animals; Aryl Hydrocarbon Hydroxylases; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Brain; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Erythromycin; Genes, MDR; Humans; Indoles; Injections, Intravenous; Male; Mice; Mice, Mutant Strains; Miconazole; Microsomes, Liver; Oxazolidinones; Oxidoreductases, N-Demethylating; Phenotype; Piperidines; Pyrrolidines; Recombinant Proteins; Statistics as Topic; Sumatriptan; Triazoles; Troleandomycin; Tryptamines

2003
Investigation of the effects of naratriptan, rizatriptan, and sumatriptan on jugular venous oxygen saturation in anesthetized pigs: implications for their mechanism of acute antimigraine action.
    The Journal of pharmacology and experimental therapeutics, 2003, Volume: 307, Issue:1

    Topics: Anesthesia; Animals; Blood Gas Analysis; Hemodynamics; Indoles; Jugular Veins; Male; Migraine Disorders; Oxygen; Piperidines; Sumatriptan; Swine; Triazoles; Tryptamines; Vasoconstriction; Vasoconstrictor Agents

2003
[Highly selective beginning. Associated symptoms and side effects in retrospect].
    MMW Fortschritte der Medizin, 2003, May-26, Volume: 145 Suppl 2

    Topics: Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Humans; Indoles; Migraine Disorders; Oxazolidinones; Piperidines; Pyrrolidines; Receptors, Serotonin, 5-HT1; Serotonin Receptor Agonists; Sumatriptan; Triazoles; Tryptamines

2003
An in vitro interethnic comparison of monoamine oxidase activities between Japanese and Caucasian livers using rizatriptan, a serotonin receptor 1B/1D agonist, as a model drug.
    British journal of clinical pharmacology, 2003, Volume: 56, Issue:5

    Topics: Asian People; Deamination; Female; Humans; Liver; Male; Middle Aged; Monoamine Oxidase; Serotonin Receptor Agonists; Triazoles; Tryptamines; White People

2003
CNS effects of sumatriptan and rizatriptan.
    Cephalalgia : an international journal of headache, 2004, Volume: 24, Issue:1

    Topics: Adult; Affect; Brain; Cognition; Cross-Over Studies; Dizziness; Double-Blind Method; Electroencephalography; Eye Movements; Female; Headache; Humans; Hypnotics and Sedatives; Nerve Tissue Proteins; Neuropsychological Tests; Postural Balance; Reaction Time; Recognition, Psychology; Serotonin Receptor Agonists; Sumatriptan; Temazepam; Triazoles; Tryptamines

2004
Cost-effectiveness of almotriptan and rizatriptan in the treatment of acute migraine.
    Clinical therapeutics, 2003, Volume: 25, Issue:11

    Topics: Acute Disease; Cost-Benefit Analysis; Decision Support Techniques; Female; Health Care Costs; Health Services; Humans; Indoles; Male; Migraine Disorders; Serotonin Receptor Agonists; Triazoles; Tryptamines

2003
Defeating migraine pain with triptans: a race against the development of cutaneous allodynia.
    Annals of neurology, 2004, Volume: 55, Issue:1

    Topics: Administration, Oral; Adolescent; Adult; Humans; Injections; Middle Aged; Migraine Disorders; Oxazolidinones; Pain; Pain Measurement; Prospective Studies; Serotonin Receptor Agonists; Skin; Sumatriptan; Time Factors; Triazoles; Tryptamines

2004
Productivity cost benefit to employers of treating migraine with rizatriptan: a specific worksite analysis and model.
    Journal of occupational and environmental medicine, 2004, Volume: 46, Issue:1

    Topics: Absenteeism; Adult; Cost-Benefit Analysis; Efficiency; Employer Health Costs; Female; Humans; Male; Middle Aged; Migraine Disorders; Models, Economic; Serotonin Receptor Agonists; Triazoles; Tryptamines; United States; Workplace

2004
[It impairs quality of life and work time. Migraine therapy should not be left to the patients!].
    MMW Fortschritte der Medizin, 2003, Nov-27, Volume: 145, Issue:48

    Topics: Absenteeism; Anti-Inflammatory Agents, Non-Steroidal; Clinical Trials as Topic; Ergot Alkaloids; Germany; Humans; Migraine Disorders; Occupational Diseases; Quality of Life; Serotonin Receptor Agonists; Treatment Outcome; Triazoles; Tryptamines

2003
Fast onset medications through thermally generated aerosols.
    The Journal of pharmacology and experimental therapeutics, 2004, Volume: 309, Issue:2

    Topics: Administration, Inhalation; Aerosols; Animals; Dogs; Nebulizers and Vaporizers; Particle Size; Serotonin Agents; Solutions; Triazoles; Tryptamines

2004
Evaluating triptan usage.
    Headache, 2004, Volume: 44, Issue:2

    Topics: Clinical Trials as Topic; Humans; Indoles; Pharmacies; Serotonin Receptor Agonists; Spain; Triazoles; Tryptamines

2004
Liquid chromatographic method for the determination of rizatriptan in human plasma.
    Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2004, Jun-05, Volume: 805, Issue:1

    Topics: Calibration; Chromatography, High Pressure Liquid; Humans; Reproducibility of Results; Sensitivity and Specificity; Serotonin Receptor Agonists; Spectrometry, Fluorescence; Triazoles; Tryptamines

2004
Involvement of 5-HT1B receptors in triptan-induced contractile responses in guinea-pig isolated iliac artery.
    Naunyn-Schmiedeberg's archives of pharmacology, 2004, Volume: 370, Issue:1

    Topics: Animals; Benzamides; Brain; Carbazoles; Dinoprost; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Endothelium, Vascular; Female; Forecasting; Guinea Pigs; Iliac Artery; Indoles; Ketanserin; Male; Muscle Contraction; Muscle, Smooth; Oxadiazoles; Oxazolidinones; Piperazines; Piperidines; Pyrrolidines; Receptor, Serotonin, 5-HT1B; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Serotonin; Serotonin 5-HT1 Receptor Antagonists; Sumatriptan; Triazoles; Tryptamines

2004
TRIPSTAR: prioritizing oral triptan treatment attributes in migraine management.
    Acta neurologica Scandinavica, 2004, Volume: 110, Issue:3

    Topics: Administration, Oral; Adult; Data Collection; Decision Support Techniques; Dose-Response Relationship, Drug; Female; Humans; Indoles; Meta-Analysis as Topic; Migraine Disorders; Patient Satisfaction; Patient Selection; Pyrrolidines; Serotonin Receptor Agonists; Treatment Outcome; Triazoles; Tryptamines

2004
[It's possible to influence prescriptions patterns by producer-independent information].
    Lakartidningen, 2004, Aug-19, Volume: 101, Issue:34

    Topics: Community Health Centers; Drug Information Services; Drug Prescriptions; Follow-Up Studies; Guideline Adherence; Humans; Migraine Disorders; Pharmacology, Clinical; Physicians, Family; Practice Guidelines as Topic; Practice Patterns, Physicians'; Serotonin Receptor Agonists; Sweden; Triazoles; Tryptamines

2004
Evaluating triptan usage: a rebuttal.
    Headache, 2004, Volume: 44, Issue:9

    Topics: Clinical Trials as Topic; Humans; Indoles; Migraine Disorders; Serotonin Receptor Agonists; Triazoles; Tryptamines

2004
[Modern migraine therapy].
    Krankenpflege Journal, 2004, Volume: 42, Issue:5-6

    Topics: Absenteeism; Adult; Cross-Sectional Studies; Drug Utilization; Female; Germany; Humans; Migraine Disorders; Quality of Life; Serotonin Receptor Agonists; Triazoles; Tryptamines

2004
The impact of a worksite migraine intervention program on work productivity, productivity costs, and non-workplace impairment among Spanish postal service employees from an employer perspective.
    Current medical research and opinion, 2004, Volume: 20, Issue:11

    Topics: Absenteeism; Adult; Costs and Cost Analysis; Counseling; Efficiency; Female; Follow-Up Studies; Humans; Male; Migraine Disorders; Occupational Health Services; Postal Service; Serotonin Receptor Agonists; Spain; Triazoles; Tryptamines

2004
Correlation between lipophilicity and triptan outcomes.
    Headache, 2005, Volume: 45, Issue:1

    Topics: Central Nervous System Diseases; Chemical Phenomena; Chemistry, Physical; Humans; Indoles; Migraine Disorders; Oxazolidinones; Piperidines; Serotonin Receptor Agonists; Statistics as Topic; Sumatriptan; Treatment Outcome; Triazoles; Tryptamines

2005
[Migraine therapy--rapid and effective].
    Krankenpflege Journal, 2004, Volume: 42, Issue:7-10

    Topics: Clinical Trials as Topic; Drug Administration Schedule; Humans; Migraine Disorders; Secondary Prevention; Serotonin Receptor Agonists; Treatment Outcome; Triazoles; Tryptamines

2004
[Migraine].
    Kinderkrankenschwester : Organ der Sektion Kinderkrankenpflege, 2004, Volume: 23, Issue:12

    Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Calcium Channel Blockers; Child; Female; Humans; Internet; Migraine Disorders; Serotonin Receptor Agonists; Triazoles; Tryptamines

2004
Triptans induce vasoconstriction of human arteries and veins from the thoracic wall.
    Journal of cardiovascular pharmacology, 2005, Volume: 45, Issue:5

    Topics: Aged; Aged, 80 and over; Arteries; Dose-Response Relationship, Drug; Female; Humans; Indoles; Male; Middle Aged; Oxazolidinones; Piperidines; Polymerase Chain Reaction; Serotonin Receptor Agonists; Sumatriptan; Thorax; Triazoles; Tryptamines; Vasoconstriction; Veins

2005
Triptan-induced contractile (5-HT1B receptor) responses in human cerebral and coronary arteries: relationship to clinical effect.
    Clinical science (London, England : 1979), 2005, Volume: 109, Issue:3

    Topics: Adult; Cerebral Arteries; Coronary Artery Disease; Coronary Vessels; Dose-Response Relationship, Drug; Female; Humans; In Vitro Techniques; Male; Middle Aged; Pyrrolidines; Receptor, Serotonin, 5-HT1B; Serotonin 5-HT1 Receptor Agonists; Serotonin Receptor Agonists; Sumatriptan; Triazoles; Tryptamines; Vasoconstriction; Vasoconstrictor Agents; Vasomotor System

2005
Triptans for migraine therapy: a comparison based on number needed to treat and doses needed to treat.
    Journal of managed care pharmacy : JMCP, 2005, Volume: 11, Issue:5

    Topics: Algorithms; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Costs; Humans; Managed Care Programs; Migraine Disorders; Piperidines; Pyrrolidines; Recurrence; Serotonin Receptor Agonists; Time Factors; Treatment Outcome; Triazoles; Tryptamines

2005
Effects of 5-HT1B/1D receptor agonist rizatriptan on cerebral blood flow and blood volume in normal circulation.
    Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2006, Volume: 26, Issue:1

    Topics: Adult; Blood Volume; Brain; Brain Mapping; Cerebrovascular Circulation; Humans; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Reference Values; Sensitivity and Specificity; Serotonin 5-HT1 Receptor Agonists; Serotonin Receptor Agonists; Time Factors; Triazoles; Tryptamines

2006
Determination of rizatriptan in human plasma by liquid chromatographic-eletrospray tandem mass spectrometry: application to a pharmacokinetic study.
    Biomedical chromatography : BMC, 2006, Volume: 20, Issue:1

    Topics: Calibration; Humans; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Serotonin Receptor Agonists; Spectrometry, Mass, Electrospray Ionization; Triazoles; Tryptamines

2006
An economic evaluation of rizatriptan in the treatment of migraine.
    PharmacoEconomics, 2005, Volume: 23, Issue:8

    Topics: Canada; Cost-Benefit Analysis; Decision Trees; Humans; Migraine Disorders; Reproducibility of Results; Serotonin Receptor Agonists; Triazoles; Tryptamines

2005
Exposure to rizatriptan during pregnancy: post-marketing experience up to 30 June 2004.
    Cephalalgia : an international journal of headache, 2005, Volume: 25, Issue:9

    Topics: Abnormalities, Drug-Induced; Female; Humans; Pregnancy; Pregnancy Outcome; Registries; Serotonin Receptor Agonists; Triazoles; Tryptamines

2005
Clinical-biochemical correlates of migraine attacks in rizatriptan responders and non-responders.
    Cephalalgia : an international journal of headache, 2006, Volume: 26, Issue:3

    Topics: Calcitonin Gene-Related Peptide; Drug Resistance; Humans; Immunoenzyme Techniques; Migraine Disorders; Neurokinin A; Serotonin Receptor Agonists; Triazoles; Tryptamines; Vasoactive Intestinal Peptide

2006
Company reference estimates for productivity loss due to migraine and productivity gains using rizatriptan 10 mg in Germany.
    International journal of clinical practice, 2006, Volume: 60, Issue:3

    Topics: Absenteeism; Adult; Aged; Cost of Illness; Efficiency; Female; Germany; Humans; Male; Middle Aged; Migraine Disorders; Prevalence; Serotonin Receptor Agonists; Triazoles; Tryptamines

2006
[Medical treatment of migraine attacks in the child].
    Revue de l'infirmiere, 2006, Issue:117

    Topics: Acetaminophen; Age Factors; Analgesics; Anti-Inflammatory Agents, Non-Steroidal; Child; Ergot Alkaloids; Humans; Ibuprofen; Life Style; Migraine Disorders; Oxazolidinones; Parents; Patient Education as Topic; Pediatrics; Piperidines; Pyrrolidines; Risk Factors; Serotonin Receptor Agonists; Sumatriptan; Taste Disorders; Triazoles; Tryptamines; Vasoconstrictor Agents

2006
Development and validation of a specific stability indicating high performance liquid chromatographic method for rizatriptan benzoate.
    Journal of pharmaceutical and biomedical analysis, 2006, Jun-16, Volume: 41, Issue:4

    Topics: Chromatography, High Pressure Liquid; Drug Contamination; Reproducibility of Results; Serotonin Receptor Agonists; Triazoles; Tryptamines

2006
Renal infarction during the use of rizatriptan and zolmitriptan: two case reports.
    Clinical toxicology (Philadelphia, Pa.), 2006, Volume: 44, Issue:2

    Topics: Adult; Cluster Headache; Humans; Infarction; Kidney; Male; Middle Aged; Migraine Disorders; Oxazolidinones; Serotonin Receptor Agonists; Tomography, X-Ray Computed; Triazoles; Tryptamines

2006
Assessment of clinical, service, and cost outcomes of a conversion program of sumatriptan to rizatriptan ODT in primary care patients with migraine headaches.
    Journal of managed care pharmacy : JMCP, 2006, Volume: 12, Issue:3

    Topics: Female; Health Maintenance Organizations; Humans; Male; Medical Records Systems, Computerized; Middle Aged; Migraine Disorders; Patient Satisfaction; Primary Health Care; Retrospective Studies; Serotonin Receptor Agonists; Sumatriptan; Surveys and Questionnaires; Treatment Outcome; Triazoles; Tryptamines

2006
Evaluation of disintegrating time of rapidly disintegrating tablets by a paddle method.
    Pharmaceutical development and technology, 2006, Volume: 11, Issue:3

    Topics: Chemistry, Pharmaceutical; Drug Compounding; Evaluation Studies as Topic; Excipients; Reproducibility of Results; Serotonin Receptor Agonists; Solubility; Tablets; Technology, Pharmaceutical; Time Factors; Triazoles; Tryptamines

2006
Development and validation of a selective and robust LC-MS/MS method for high-throughput quantifying rizatriptan in small plasma samples: application to a clinical pharmacokinetic study.
    Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2006, Dec-05, Volume: 844, Issue:2

    Topics: Adult; Chromatography, High Pressure Liquid; Granisetron; Humans; Male; Molecular Structure; Reference Standards; Reproducibility of Results; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry; Triazoles; Tryptamines

2006
Increasing the effect of triptans in migraine.
    Lancet (London, England), 2006, Oct-14, Volume: 368, Issue:9544

    Topics: Cross-Over Studies; Drug Therapy, Combination; Gastrointestinal Agents; Humans; Migraine Disorders; Randomized Controlled Trials as Topic; Serotonin Receptor Agonists; Triazoles; Trimebutine; Tryptamines

2006
Transient ischemic attack after rizatriptan administration in a liver transplant recipient: a case report.
    Transplantation proceedings, 2006, Volume: 38, Issue:9

    Topics: Adult; Humans; Ischemic Attack, Transient; Liver Transplantation; Male; Migraine Disorders; Postoperative Complications; Serotonin Receptor Agonists; Treatment Outcome; Triazoles; Tryptamines

2006
A pharmacoeconomic evaluation of oral triptans in the treatment of migraine in Italy.
    Minerva medica, 2006, Volume: 97, Issue:6

    Topics: Administration, Oral; Cost-Benefit Analysis; Decision Trees; Humans; Italy; Migraine Disorders; Sensitivity and Specificity; Triazoles; Tryptamines

2006
Uptake and biodistribution of rizatriptan to blood and brain following different routes of administration in rats.
    International journal of pharmaceutics, 2007, Jun-07, Volume: 337, Issue:1-2

    Topics: Administration, Intranasal; Administration, Oral; Animals; Area Under Curve; Biological Availability; Blood-Brain Barrier; Brain; Chromatography, High Pressure Liquid; Injections, Subcutaneous; Intubation, Intratracheal; Male; Metabolic Clearance Rate; Rats; Rats, Wistar; Serotonin Receptor Agonists; Triazoles; Tryptamines

2007
Investigation of low levels of plasma valproic acid concentration following simultaneous administration of sodium valproate and rizatriptan benzoate.
    The Journal of pharmacy and pharmacology, 2007, Volume: 59, Issue:3

    Topics: Animals; Anticonvulsants; Drug Interactions; Male; Monocarboxylic Acid Transporters; Rats; Rats, Sprague-Dawley; Serotonin Receptor Agonists; Triazoles; Tryptamines; Valproic Acid

2007
Comment on eletriptan in migraine patients reporting unsatisfactory response to rizatriptan.
    Headache, 2007, Volume: 47, Issue:3

    Topics: Humans; Migraine Disorders; Patient Satisfaction; Pyrrolidines; Retreatment; Serotonin Receptor Agonists; Triazoles; Tryptamines

2007
Times to pain relief and pain freedom with rizatriptan 10 mg and other oral triptans.
    International journal of clinical practice, 2007, Volume: 61, Issue:7

    Topics: Acute Disease; Adult; Cross-Over Studies; Female; Humans; Male; Middle Aged; Migraine Disorders; Multivariate Analysis; Patient Satisfaction; Prospective Studies; Serotonin Receptor Agonists; Time Factors; Treatment Outcome; Triazoles; Tryptamines

2007
Association study between clinical response to rizatriptan and some candidate genes.
    The journal of headache and pain, 2007, Volume: 8, Issue:3

    Topics: Adult; Alleles; Drug Resistance; Female; Genotype; Humans; Male; Middle Aged; Migraine without Aura; Monoamine Oxidase; Polymorphism, Genetic; Prospective Studies; Receptor, Serotonin, 5-HT1B; Receptors, Dopamine D2; Reverse Transcriptase Polymerase Chain Reaction; Serotonin Plasma Membrane Transport Proteins; Serotonin Receptor Agonists; Treatment Outcome; Triazoles; Tryptamines

2007
Glutamate levels in cerebrospinal fluid and triptans overuse in chronic migraine.
    Headache, 2007, Volume: 47, Issue:6

    Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Female; Glutamic Acid; Headache Disorders; Headache Disorders, Secondary; Humans; Male; Middle Aged; Migraine Disorders; Piperidines; Serotonin Receptor Agonists; Triazoles; Tryptamines

2007
[Bonus-malus regulations in the framework of the AVWG guideline-suitable migraine therapy are possible].
    MMW Fortschritte der Medizin, 2007, May-21, Volume: 149 Suppl 2

    Topics: Clinical Trials as Topic; Cross-Over Studies; Drug and Narcotic Control; Germany; Humans; Migraine Disorders; Multicenter Studies as Topic; Patient Satisfaction; Practice Guidelines as Topic; Prospective Studies; Serotonin Receptor Agonists; Sumatriptan; Time Factors; Triazoles; Tryptamines; Vasoconstrictor Agents

2007
Simultaneous determination of amiloride and hydrochlorothiazide in human plasma by liquid chromatography/tandem mass spectrometry with positive/negative ion-switching electrospray ionisation.
    Rapid communications in mass spectrometry : RCM, 2007, Volume: 21, Issue:21

    Topics: Administration, Oral; Amiloride; Chromatography, High Pressure Liquid; Diuretics; Drug Therapy, Combination; Humans; Hydrochlorothiazide; Male; Reproducibility of Results; Serotonin Receptor Agonists; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry; Triazoles; Tryptamines

2007
Identification of aquaporin 4 inhibitors using in vitro and in silico methods.
    Bioorganic & medicinal chemistry, 2009, Jan-01, Volume: 17, Issue:1

    Topics: Aquaporin 4; Computer Simulation; Humans; Inhibitory Concentration 50; Serotonin Receptor Agonists; Sumatriptan; Triazoles; Tryptamines; Vasoconstrictor Agents

2009
[A new therapeutic principle for migraine].
    Ugeskrift for laeger, 2008, Mar-17, Volume: 170, Issue:12

    Topics: Azepines; Calcitonin Gene-Related Peptide; Humans; Imidazoles; Migraine Disorders; Piperazines; Quinazolines; Serotonin Receptor Agonists; Treatment Outcome; Triazoles; Tryptamines; Vasodilator Agents

2008
Comparison of rizatriptan and sumatriptan.
    Headache, 1999, Volume: 39, Issue:1

    Topics: Humans; Migraine Disorders; Patient Satisfaction; Serotonin Receptor Agonists; Sumatriptan; Time Factors; Triazoles; Tryptamines; Vasoconstrictor Agents

1999
Elastic liposomal formulation for sustained delivery of antimigraine drug: in vitro characterization and biological evaluation.
    Drug development and industrial pharmacy, 2008, Volume: 34, Issue:10

    Topics: Animals; Chemistry, Pharmaceutical; Delayed-Action Preparations; Elasticity; Hyperalgesia; Liposomes; Male; Mice; Microscopy, Electron, Scanning; Migraine Disorders; Rats; Rats, Wistar; Skin; Solubility; Triazoles; Tryptamines

2008
Identification, isolation and characterization of process-related impurities in Rizatriptan benzoate.
    Journal of pharmaceutical and biomedical analysis, 2009, Jan-15, Volume: 49, Issue:1

    Topics: Chromatography, High Pressure Liquid; Drug Contamination; Magnetic Resonance Spectroscopy; Mass Spectrometry; Molecular Structure; Reproducibility of Results; Serotonin Receptor Agonists; Spectrophotometry, Infrared; Triazoles; Tryptamines

2009
Alcohol and cluster headaches.
    Headache, 2009, Volume: 49, Issue:1

    Topics: Alcohol Drinking; Cluster Headache; Humans; Male; Middle Aged; Oxazolidinones; Serotonin Receptor Agonists; Smoking; Triazoles; Tryptamines

2009
10 years of rizatriptan.
    Headache, 2009, Volume: 49 Suppl 1

    Topics: History, 20th Century; History, 21st Century; Humans; Migraine Disorders; Serotonin Receptor Agonists; Triazoles; Tryptamines

2009
Age effects on placebo response rates in clinical trials of acute agents for migraine: pooled analysis of rizatriptan trials in adults.
    Cephalalgia : an international journal of headache, 2009, Volume: 29, Issue:7

    Topics: Adolescent; Adult; Age Factors; Aged; Female; Humans; Male; Middle Aged; Migraine Disorders; Placebo Effect; Randomized Controlled Trials as Topic; Serotonin Receptor Agonists; Triazoles; Tryptamines; Young Adult

2009
[Utilizing the strength(s) of rizatriptan 10 mg: cost effective against migraine attacks].
    MMW Fortschritte der Medizin, 2009, Mar-26, Volume: 151, Issue:13

    Topics: Administration, Sublingual; Cost-Benefit Analysis; Dose-Response Relationship, Drug; Drug Costs; Humans; Migraine Disorders; Randomized Controlled Trials as Topic; Serotonin Receptor Agonists; Treatment Outcome; Triazoles; Tryptamines

2009
Rizatriptan. Convenience and consistency.
    Postgraduate medicine, 2000, Volume: 108, Issue:3 Suppl

    Topics: Acute Disease; Administration, Oral; Humans; Migraine Disorders; Serotonin Receptor Agonists; Tablets; Triazoles; Tryptamines

2000
Evaluating the efficacy of migraine therapy.
    Postgraduate medicine, 2000, Volume: 108, Issue:3 Suppl

    Topics: Humans; Migraine Disorders; Serotonin Receptor Agonists; Sumatriptan; Time Factors; Treatment Outcome; Triazoles; Tryptamines; Vasoconstrictor Agents

2000
Rizatriptan. Comparative trial results.
    Postgraduate medicine, 2000, Volume: 108, Issue:3 Suppl

    Topics: Adolescent; Adult; Aged; Female; Humans; Male; Middle Aged; Migraine Disorders; Oxazolidinones; Piperidines; Serotonin Receptor Agonists; Time Factors; Treatment Outcome; Triazoles; Tryptamines; Vasoconstrictor Agents; Young Adult

2000
A study of triggers of migraine in India.
    Pain medicine (Malden, Mass.), 2010, Volume: 11, Issue:1

    Topics: Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Diet; Disability Evaluation; Eating; Female; Humans; Ibuprofen; India; Male; Middle Aged; Migraine Disorders; Pain Measurement; Physical Exertion; Prognosis; Prospective Studies; Serotonin Receptor Agonists; Sleep Deprivation; Stress, Psychological; Triazoles; Tryptamines; Weather; Young Adult

2010
Rizatriptan induced acute on top of chronic ischemic colitis.
    The American journal of gastroenterology, 2009, Volume: 104, Issue:10

    Topics: Colitis, Ischemic; Colonoscopy; Diagnosis, Differential; Female; Humans; Middle Aged; Migraine Disorders; Serotonin Receptor Agonists; Triazoles; Tryptamines

2009
Brain apparent water diffusion coefficient magnetic resonance image during a prolonged visual aura.
    Headache, 2010, Volume: 50, Issue:6

    Topics: Adult; Analgesics, Non-Narcotic; Brain; Brain Mapping; Diffusion Magnetic Resonance Imaging; Female; Humans; Ibuprofen; Image Processing, Computer-Assisted; Migraine with Aura; Serotonin Receptor Agonists; Triazoles; Tryptamines

2010
Arterial spin-labeled MRI study of migraine attacks treated with rizatriptan.
    The journal of headache and pain, 2010, Volume: 11, Issue:3

    Topics: Adult; Cerebral Arteries; Cerebrovascular Circulation; Cerebrovascular Disorders; Functional Laterality; Humans; Hyperemia; Hypothalamus; Magnetic Resonance Imaging; Male; Migraine Disorders; Prefrontal Cortex; Serotonin Receptor Agonists; Thalamus; Time Factors; Treatment Outcome; Triazoles; Tryptamines

2010
The Fos expression in rat brain following electrical stimulation of dura mater surrounding the superior sagittal sinus changed with the pre-treatment of rizatriptan benzoate.
    Brain research, 2011, Jan-07, Volume: 1367

    Topics: Animals; Brain; Cell Count; Dura Mater; Electric Stimulation; Gene Expression Regulation; Male; Neurons; Oncogene Proteins v-fos; Rats; Rats, Sprague-Dawley; Serotonin Receptor Agonists; Statistics, Nonparametric; Superior Sagittal Sinus; Triazoles; Tryptamines; Wakefulness

2011
Nociceptive behaviors were induced by electrical stimulation of the dura mater surrounding the superior sagittal sinus in conscious adult rats and reduced by morphine and rizatriptan benzoate.
    Brain research, 2011, Jan-12, Volume: 1368

    Topics: Animals; Disease Models, Animal; Dura Mater; Electric Stimulation; Grooming; Male; Morphine; Narcotics; Pain; Rats; Rats, Sprague-Dawley; Serotonin Receptor Agonists; Superior Sagittal Sinus; Treatment Outcome; Triazoles; Tryptamines; Wakefulness

2011
Rizatriptan is effective for headache in a patient with meningeal carcinomatosis.
    Journal of pain and symptom management, 2011, Volume: 41, Issue:5

    Topics: Brain Neoplasms; Female; Headache; Humans; Meningeal Carcinomatosis; Middle Aged; Serotonin Receptor Agonists; Treatment Outcome; Triazoles; Tryptamines

2011
Evolution of paediatric off-label use after new significant medicines become available for adults: a study on triptans in Finnish children 1994-2007.
    British journal of clinical pharmacology, 2011, Volume: 71, Issue:6

    Topics: Adolescent; Adult; Age Factors; Child; Drug Approval; Female; Finland; Humans; Male; Migraine Disorders; Off-Label Use; Oxazolidinones; Serotonin 5-HT1 Receptor Agonists; Sumatriptan; Time Factors; Triazoles; Tryptamines; Young Adult

2011
An approach for rapid development of nasal delivery of analgesics--identification of relevant features, in vitro screening and in vivo verification.
    International journal of pharmaceutics, 2011, Nov-25, Volume: 420, Issue:1

    Topics: Absorption; Administration, Intranasal; Administration, Oral; Analgesics; Animals; Area Under Curve; Benzopyrans; Cell Line; Drug Stability; Ethanolamines; Feasibility Studies; Humans; Hydrogen-Ion Concentration; Injections, Intravenous; Male; Meloxicam; Nasal Mucosa; Nebivolol; Permeability; Piroxicam; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Respiratory Mucosa; Thiazines; Thiazoles; Triazoles; Tryptamines

2011
Implication of free cholesterol in LC-MS response enhancement.
    Bioanalysis, 2012, Volume: 4, Issue:10

    Topics: Animals; Cholesterol; Chromatography, Liquid; Cyclohexanols; Humans; Ketoconazole; Liquid-Liquid Extraction; Pharmaceutical Preparations; Plasma; Rats; Solid Phase Extraction; Tandem Mass Spectrometry; Triazoles; Tryptamines; Venlafaxine Hydrochloride

2012
[Rizatriptan-induced liver toxicity. Report of a case].
    Gastroenterologia y hepatologia, 2013, Volume: 36, Issue:4

    Topics: Adolescent; Chemical and Drug Induced Liver Injury; Female; Humans; Immune Complex Diseases; Jaundice, Obstructive; Migraine Disorders; Serotonin Receptor Agonists; Time Factors; Triazoles; Tryptamines

2013
Two mechanisms involved in trigeminal CGRP release: implications for migraine treatment.
    Headache, 2013, Volume: 53, Issue:1

    Topics: Analgesics; Animals; Blotting, Western; Botulinum Toxins, Type A; Calcitonin Gene-Related Peptide; Cells, Cultured; Immunohistochemistry; Migraine Disorders; Neurons; Radioimmunoassay; Rats; Rats, Sprague-Dawley; Triazoles; Trigeminal Ganglion; Tryptamines

2013
Modulation of CGRP-induced light aversion in wild-type mice by a 5-HT(1B/D) agonist.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2012, Oct-31, Volume: 32, Issue:44

    Topics: Animals; Anxiety; Behavior, Animal; Calcitonin Gene-Related Peptide; Female; Light; Male; Mice; Mice, Inbred C57BL; Motor Activity; Photic Stimulation; Photophobia; Receptor, Serotonin, 5-HT1B; Serotonin Receptor Agonists; Triazoles; Tryptamines

2012
Development and evaluation of tamarind seed xyloglucan-based mucoadhesive buccal films of rizatriptan benzoate.
    Carbohydrate polymers, 2013, Jan-16, Volume: 91, Issue:2

    Topics: Adhesives; Administration, Buccal; Animals; Drug Delivery Systems; Glucans; Membranes, Artificial; Mouth Mucosa; Serotonin Receptor Agonists; Swine; Tamarindus; Tensile Strength; Triazoles; Tryptamines; Xylans

2013
Behavioral evidence for photophobia and stress-related ipsilateral head pain in transgenic Cacna1a mutant mice.
    Pain, 2013, Volume: 154, Issue:8

    Topics: Analgesics; Animals; Calcium Channels, L-Type; Calcium Channels, N-Type; Disease Models, Animal; Dose-Response Relationship, Drug; Feces; Female; Functional Laterality; Headache; Male; Mice; Mice, Transgenic; Morphine; Mutation; Pain Measurement; Photophobia; Stress, Psychological; Triazoles; Tryptamines

2013
Frovatriptan vs. other triptans for the acute treatment of oral contraceptive-induced menstrual migraine: pooled analysis of three double-blind, randomized, crossover, multicenter studies.
    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2013, Volume: 34 Suppl 1

    Topics: Carbazoles; Contraceptives, Oral, Hormonal; Cross-Over Studies; Double-Blind Method; Female; Humans; Menstruation; Migraine Disorders; Multicenter Studies as Topic; Oxazolidinones; Premenstrual Syndrome; Randomized Controlled Trials as Topic; Serotonin Receptor Agonists; Triazoles; Tryptamines

2013
[Expectation is one half of therapy].
    MMW Fortschritte der Medizin, 2014, Jun-12, Volume: 156, Issue:11

    Topics: Analgesics; Culture; Humans; Migraine Disorders; Placebo Effect; Randomized Controlled Trials as Topic; Triazoles; Tryptamines

2014
Effects of rizatriptan on the expression of calcitonin gene-related peptide and cholecystokinin in the periaqueductal gray of a rat migraine model.
    Neuroscience letters, 2015, Feb-05, Volume: 587

    Topics: Animals; Calcitonin Gene-Related Peptide; Cholecystokinin; Female; Male; Migraine Disorders; Periaqueductal Gray; Rats, Wistar; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; RNA, Messenger; Serotonin 5-HT1 Receptor Agonists; Triazoles; Tryptamines

2015
Development and validation of UV spectrophotometric method to study stress degradation behaviour of rizatriptan benzoate.
    Guang pu xue yu guang pu fen xi = Guang pu, 2015, Volume: 35, Issue:1

    Topics: Hydrogen-Ion Concentration; Serotonin Receptor Agonists; Spectrophotometry, Ultraviolet; Triazoles; Tryptamines

2015
Bioavailability Enhancement of Rizatriptan Benzoate by Oral Disintegrating Strip: In vitro and In vivo Evaluation.
    Current drug delivery, 2016, Volume: 13, Issue:3

    Topics: Administration, Oral; Animals; Biological Availability; Drug Delivery Systems; Drug Liberation; Drug Stability; Female; Male; Migraine Disorders; Mouth Mucosa; Rats; Rats, Sprague-Dawley; Serotonin Receptor Agonists; Sheep; Solubility; Tablets; Tensile Strength; Triazoles; Tryptamines

2016
An electrochemical sensor for rizatriptan benzoate determination using Fe3O4 nanoparticle/multiwall carbon nanotube-modified glassy carbon electrode in real samples.
    Materials science & engineering. C, Materials for biological applications, 2016, Volume: 63

    Topics: Biosensing Techniques; Carbon; Electrochemical Techniques; Electrodes; Ferrosoferric Oxide; Humans; Hydrogen-Ion Concentration; Limit of Detection; Magnetite Nanoparticles; Microscopy, Electron, Scanning; Microscopy, Electron, Transmission; Nanotubes, Carbon; Spectrometry, X-Ray Emission; Surface Properties; Tablets; Triazoles; Tryptamines; X-Ray Diffraction

2016
Multivariate Optimization of Rizatriptan Benzoate-Loaded Solid Lipid Nanoparticles for Brain Targeting and Migraine Management.
    AAPS PharmSciTech, 2017, Volume: 18, Issue:2

    Topics: Administration, Oral; Animals; Brain; Chemistry, Pharmaceutical; Delayed-Action Preparations; Drug Carriers; Drug Delivery Systems; Drug Liberation; Lipids; Male; Mice; Migraine Disorders; Nanoparticles; Particle Size; Rats; Rats, Wistar; Surface-Active Agents; Triazoles; Tryptamines

2017
Rizatriptan overuse promotes hyperalgesia induced by dural inflammatory stimulation in rats by modulation of the serotonin system.
    The European journal of neuroscience, 2016, Volume: 44, Issue:4

    Topics: Animals; Cerebral Cortex; Headache Disorders, Secondary; Hyperalgesia; Inflammation; Male; Pain; Rats, Sprague-Dawley; Serotonin; Triazoles; Tryptamines

2016
Triazole rizatriptan Induces Liver Toxicity through Lysosomal/Mitochondrial Dysfunction.
    Drug research, 2016, Volume: 66, Issue:9

    Topics: Animals; Antioxidants; Cell Death; Cytochrome P-450 Enzyme Inducers; Dose-Response Relationship, Drug; Hepatocytes; Liver; Lysosomes; Membrane Potential, Mitochondrial; Mitochondria; Oxidative Stress; Rats; Triazoles; Tryptamines

2016
Utilization of Liver Microsomes to Estimate Hepatic Intrinsic Clearance of Monoamine Oxidase Substrate Drugs in Humans.
    Pharmaceutical research, 2017, Volume: 34, Issue:6

    Topics: Humans; Kinetics; Metabolic Clearance Rate; Microsomes, Liver; Monoamine Oxidase; Phenylephrine; Sumatriptan; Triazoles; Tryptamines

2017
Does the Anti-Migraine Drug Rizatriptan Affect Early Neural Tube Development in Chick Embryos?
    Turkish neurosurgery, 2019, Volume: 29, Issue:1

    Topics: Animals; Chick Embryo; Chickens; Embryonic Development; Neural Tube; Neural Tube Defects; Serotonin Receptor Agonists; Triazoles; Tryptamines

2019
Design and optimization of kollicoat ® IR based mucoadhesive buccal film for co-delivery of rizatriptan benzoate and propranolol hydrochloride.
    Materials science & engineering. C, Materials for biological applications, 2019, Volume: 97

    Topics: Adhesiveness; Adhesives; Administration, Buccal; Animals; Biocompatible Materials; Calorimetry, Differential Scanning; Drug Combinations; Drug Compounding; Drug Delivery Systems; Drug Liberation; Microscopy, Electron, Scanning; Mouth Mucosa; Polyvinyls; Propranolol; Rats; Spectroscopy, Fourier Transform Infrared; Tensile Strength; Triazoles; Tryptamines

2019
Simultaneous voltammetric determination of rizatriptan and acetaminophen using a carbon paste electrode modified with NiFe
    Mikrochimica acta, 2020, 05-07, Volume: 187, Issue:6

    Topics: Acetaminophen; Carbon; Electrochemical Techniques; Electrodes; Ferric Compounds; Humans; Limit of Detection; Metal Nanoparticles; Nickel; Oxidation-Reduction; Tablets; Triazoles; Tryptamines

2020
Comparative assessment of in vitro/in vivo performances of orodispersible electrospun and casting films containing rizatriptan benzoate.
    European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 2020, Volume: 154

    Topics: Administration, Oral; Animals; Chemistry, Pharmaceutical; Drug Carriers; Drug Delivery Systems; Drug Liberation; Male; Random Allocation; Rats; Rats, Sprague-Dawley; Serotonin Receptor Agonists; Triazoles; Tryptamines; X-Ray Diffraction

2020
Transfer of triptans into human breast milk and estimation of infant drug exposure through breastfeeding.
    Basic & clinical pharmacology & toxicology, 2021, Volume: 128, Issue:6

    Topics: Adult; Breast Feeding; Female; Humans; Infant; Infant, Newborn; Migraine Disorders; Milk, Human; Oxazolidinones; Piperidines; Pyrrolidines; Triazoles; Tryptamines

2021
Formulation and Characterization of Nanostructured Lipid Carriers of Rizatriptan Benzoate-Loaded
    Assay and drug development technologies, 2022, Volume: 20, Issue:5

    Topics: Brain; Drug Carriers; Gels; Lipids; Nanostructures; Triazoles; Tryptamines

2022